Identification	O
of	O
a	O
Wnt	B
-	O
responsive	O
signal	O
transduction	O
pathway	O
in	O
primary	O
endothelial	O
cells	O
.	O

The	O
beta	B
-	I
catenin	I
signal	O
transduction	O
pathway	O
,	O
which	O
can	O
be	O
activated	O
by	O
secreted	O
Wnt	B
proteins	O
,	O
plays	O
a	O
key	O
role	O
in	O
normal	O
embryonic	O
development	O
and	O
in	O
malignant	O
transformation	O
of	O
the	O
mammary	O
gland	O
and	O
colon	O
.	O

Here	O
we	O
demonstrate	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
Wnt	B
and	O
beta	B
-	I
catenin	I
signaling	O
also	O
function	O
in	O
cells	O
of	O
the	O
vasculature	O
.	O

RT	O
-	O
PCR	O
analysis	O
showed	O
that	O
primary	O
endothelial	O
and	O
smooth	O
muscle	O
cell	O
cultures	O
,	O
of	O
both	O
mouse	O
and	O
human	O
origin	O
,	O
express	O
members	O
of	O
the	O
Wnt	B
and	O
Wnt	B
receptor	O
(	O
Frizzled	O
)	O
gene	O
families	O
.	O

Transfection	O
of	O
an	O
expression	O
vector	O
for	O
Wnt-1	B
into	O
primary	O
endothelial	O
cells	O
increased	O
both	O
the	O
free	O
pool	O
of	O
beta	B
-	I
catenin	I
and	O
the	O
transcription	O
from	O
a	O
Lef	O
/	O
tcf	O
-	O
dependent	O
reporter	O
gene	O
construct	O
.	O

Expression	O
of	O
Wnt-1	B
,	O
but	O
not	O
Wnt-5a	B
,	O
also	O
stimulated	O
proliferation	O
of	O
primary	O
endothelial	O
cell	O
cultures	O
.	O

These	O
data	O
show	O
that	O
Wnt	B
and	O
Frizzled	O
proteins	O
can	O
regulate	O
signal	O
transduction	O
,	O
via	O
beta	B
-	I
catenin	I
,	O
in	O
endothelial	O
cells	O
.	O

These	O
findings	O
suggest	O
that	O
Wnt	B
signaling	O
may	O
feature	O
in	O
normal	O
differentiation	O
of	O
the	O
vasculature	O
as	O
well	O
as	O
in	O
pathological	O
settings	O
where	O
endothelial	O
and	O
smooth	O
muscle	O
proliferation	O
is	O
disturbed	O
.	O

The	O
VacA	O
toxin	O
of	O
Helicobacter	O
pylori	O
identifies	O
a	O
new	O
intermediate	O
filament	O
-	O
interacting	O
protein	O
.	O

The	O
VacA	O
toxin	O
produced	O
by	O
Helicobacter	O
pylori	O
acts	O
inside	O
cells	O
and	O
induces	O
the	O
formation	O
of	O
vacuoles	O
arising	O
from	O
late	O
endosomal	O
/	O
lysosomal	O
compartments	O
.	O

Using	O
VacA	O
as	O
bait	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screening	O
of	O
a	O
HeLa	O
cell	O
library	O
,	O
we	O
have	O
identified	O
a	O
novel	O
protein	O
of	O
54	O
kDa	O
(	O
VIP54	B
)	O
,	O
which	O
interacts	O
specifically	O
with	O
VacA	O
,	O
as	O
indicated	O
by	O
co	O
-	O
immunoprecipitation	O
and	O
binding	O
experiments	O
.	O

VIP54	B
is	O
expressed	O
in	O
cultured	O
cells	O
and	O
many	O
tissues	O
,	O
with	O
higher	O
expression	O
in	O
the	O
brain	O
,	O
muscle	O
,	O
kidney	O
and	O
liver	O
.	O

Confocal	O
immunofluorescence	O
microscopy	O
with	O
anti	O
-	O
VIP54	B
affinity-	O
purified	O
antibodies	O
shows	O
a	O
fibrous	O
pattern	O
typical	O
of	O
intermediate	O
filaments	O
.	O

Double	O
label	O
immunofluorescence	O
performed	O
on	O
various	O
cell	O
lines	O
with	O
antibodies	O
specific	O
to	O
different	O
intermediate	O
filament	O
proteins	O
revealed	O
that	O
VIP54	B
largely	O
co	O
-	O
distributes	O
with	O
vimentin	B
.	O

In	O
contrast	O
to	O
known	O
intermediate	O
filament	O
proteins	O
,	O
VIP54	B
is	O
predicted	O
to	O
contain	O
approximately	O
50	O
%	O
of	O
helical	O
segments	O
,	O
but	O
no	O
extended	O
coiled	O
-	O
coil	O
regions	O
.	O

The	O
possible	O
involvement	O
of	O
this	O
novel	O
protein	O
in	O
interactions	O
between	O
intermediate	O
filaments	O
and	O
late	O
endosomal	O
compartments	O
is	O
discussed	O
.	O

Identification	O
and	O
characterization	O
of	O
a	O
new	O
human	O
ETS	O
-	O
family	O
transcription	O
factor	O
,	O
TEL2	B
,	O
that	O
is	O
expressed	O
in	O
hematopoietic	O
tissues	O
and	O
can	O
associate	O
with	O
TEL1	B
/	O
ETV6	B
.	O

The	O
ETS	O
family	O
of	O
proteins	O
is	O
a	O
large	O
group	O
of	O
transcription	O
factors	O
implicated	O
in	O
many	O
aspects	O
of	O
normal	O
hematopoietic	O
development	O
,	O
as	O
well	O
as	O
oncogenesis	O
.	O

For	O
example	O
,	O
the	O
TEL1	B
/	O
ETV6	B
(	O
TEL1	B
)	O
gene	O
is	O
required	O
for	O
normal	O
yolk	O
sac	O
angiogenesis	O
,	O
adult	O
bone	O
marrow	O
hematopoiesis	O
,	O
and	O
is	O
rearranged	O
or	O
deleted	O
in	O
numerous	O
leukemias	O
.	O

This	O
report	O
describes	O
the	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
ETS	O
gene	O
that	O
is	O
highly	O
related	O
to	O
TEL1	B
and	O
is	O
therefore	O
called	O
TEL2	B
.	O

The	O
TEL2	B
gene	O
consists	O
of	O
8	O
exons	O
spanning	O
approximately	O
21	O
kilobases	O
(	O
kb	O
)	O
in	O
human	O
chromosome	O
6p21	O
.	O

Unlike	O
the	O
ubiquitously	O
expressed	O
TEL1	B
gene	O
,	O
however	O
,	O
TEL2	B
appears	O
to	O
be	O
expressed	O
predominantly	O
in	O
hematopoietic	O
tissues	O
.	O

Antibodies	O
raised	O
against	O
the	O
C	O
-	O
terminus	O
of	O
the	O
TEL2	B
protein	O
were	O
used	O
to	O
show	O
that	O
TEL2	B
localizes	O
to	O
the	O
nucleus	O
.	O

All	O
ETS	O
proteins	O
can	O
bind	O
DNA	O
via	O
the	O
highly	O
conserved	O
ETS	O
domain	O
,	O
which	O
recognizes	O
a	O
purine	O
-	O
rich	O
DNA	O
sequence	O
with	O
a	O
GGAA	O
core	O
motif	O
.	O

DNA	O
binding	O
assays	O
show	O
that	O
TEL2	B
can	O
bind	O
the	O
same	O
consensus	O
DNA	O
binding	O
sequence	O
recognized	O
by	O
TEL1	B
/	O
ETV6	B
.	O

Additionally	O
,	O
the	O
TEL2	B
protein	O
is	O
capable	O
of	O
associating	O
with	O
itself	O
and	O
with	O
TEL1	B
in	O
doubly	O
transfected	O
Hela	O
cells	O
,	O
and	O
this	O
interaction	O
is	O
mediated	O
through	O
the	O
pointed	O
(	O
PNT	O
)	O
domain	O
of	O
TEL1	B
.	O

The	O
striking	O
similarities	O
of	O
TEL2	B
to	O
the	O
oncogenic	O
TEL1	B
,	O
its	O
expression	O
in	O
hematopoietic	O
tissues	O
,	O
and	O
its	O
ability	O
to	O
associate	O
with	O
TEL1	B
suggest	O
that	O
TEL2	B
may	O
be	O
an	O
important	O
hematopoietic	O
regulatory	O
protein	O
.	O

The	O
SCA8	O
transcript	O
is	O
an	O
antisense	O
RNA	O
to	O
a	O
brain	O
-	O
specific	O
transcript	O
encoding	O
a	O
novel	O
actin	O
-	O
binding	O
protein	O
(	O
KLHL1	B
)	O
.	O

Spinocerebellar	O
ataxia	O
type	O
8	O
(	O
SCA8	O
)	O
is	O
a	O
neurodegenerative	O
disorder	O
caused	O
by	O
the	O
expansion	O
of	O
a	O
CTG	O
trinucleotide	O
repeat	O
that	O
is	O
transcribed	O
as	O
part	O
of	O
an	O
untranslated	O
RNA	O
.	O

As	O
a	O
step	O
towards	O
understanding	O
the	O
molecular	O
pathology	O
of	O
SCA8	O
,	O
we	O
have	O
defined	O
the	O
genomic	O
organization	O
of	O
the	O
SCA8	O
RNA	O
transcripts	O
and	O
assembled	O
a	O
166	O
kb	O
segment	O
of	O
genomic	O
sequence	O
containing	O
the	O
repeat	O
.	O

The	O
most	O
striking	O
feature	O
of	O
the	O
SCA8	O
transcripts	O
is	O
that	O
the	O
most	O
5	O
'	O
exon	O
is	O
transcribed	O
through	O
the	O
first	O
exon	O
of	O
another	O
gene	O
that	O
is	O
transcribed	O
in	O
the	O
opposite	O
orientation	O
.	O

This	O
gene	O
arrangement	O
suggests	O
that	O
the	O
SCA8	O
transcript	O
is	O
an	O
endogenous	O
antisense	O
RNA	O
that	O
overlaps	O
the	O
transcription	O
and	O
translation	O
start	O
sites	O
as	O
well	O
as	O
the	O
first	O
splice	O
donor	O
sequence	O
of	O
the	O
sense	O
gene	O
.	O

The	O
sense	O
transcript	O
encodes	O
a	O
748	O
amino	O
acid	O
protein	O
with	O
a	O
predicted	O
domain	O
structure	O
typical	O
of	O
a	O
family	O
of	O
actin	O
-	O
organizing	O
proteins	O
related	O
to	O
the	O
Drosophila	O
Kelch	O
gene	O
,	O
and	O
so	O
has	O
been	O
given	O
the	O
name	O
Kelch	B
-	I
like	I
1	I
(	O
KLHL1	B
)	O
.	O

We	O
have	O
identified	O
the	O
full	O
-	O
length	O
cDNA	O
sequence	O
for	O
both	O
the	O
human	O
and	O
mouse	O
KLHLI	B
genes	O
,	O
and	O
have	O
elucidated	O
the	O
general	O
genomic	O
organization	O
of	O
the	O
human	O
gene	O
.	O

The	O
predicted	O
open	O
reading	O
frame	O
and	O
promoter	O
region	O
are	O
highly	O
conserved	O
,	O
and	O
both	O
genes	O
are	O
primarily	O
expressed	O
in	O
specific	O
brain	O
tissues	O
,	O
including	O
the	O
cerebellum	O
,	O
the	O
tissue	O
most	O
affected	O
by	O
SCA8	O
.	O

Transfection	O
studies	O
with	O
epitope	O
-	O
tagged	O
KLHL1	B
demonstrate	O
that	O
the	O
protein	O
localizes	O
to	O
the	O
cytoplasm	O
,	O
suggesting	O
that	O
it	O
may	O
play	O
a	O
role	O
in	O
organizing	O
the	O
actin	O
cytoskeleton	O
of	O
the	O
brain	O
cells	O
in	O
which	O
it	O
is	O
expressed	O
.	O

Identification	O
of	O
cDNAs	O
encoding	O
two	O
novel	O
nuclear	O
proteins	O
,	O
IMUP-1	B
and	O
IMUP-2	B
,	O
upregulated	O
in	O
SV40-immortalized	O
human	O
fibroblasts	O
.	O

Using	O
a	O
model	O
system	O
of	O
young	O
,	O
senescent	O
and	O
SV40-immortalized	O
WI-38	O
fibroblasts	O
,	O
we	O
identified	O
two	O
mRNAs	O
upregulated	O
in	O
immortalized	O
cells	O
(	O
imup-1	B
,	O
immortalization	B
-	I
upregulated	I
protein	I
1	I
,	O
and	O
imup-2	B
)	O
.	O

Compared	O
to	O
normal	O
tissues	O
,	O
both	O
genes	O
were	O
more	O
frequently	O
expressed	O
in	O
cancer	O
cells	O
.	O

The	O
open	O
reading	O
frame	O
of	O
imup-1	B
spans	O
321bp	O
,	O
coding	O
for	O
a	O
10.9	O
kDa	O
protein	O
of	O
106	O
amino	O
acids	O
,	O
while	O
an	O
insertion	O
of	O
59bp	O
in	O
the	O
otherwise	O
identical	O
mRNA	O
of	O
imup-2	B
leads	O
to	O
a	O
frameshift	O
,	O
resulting	O
in	O
an	O
8.5	O
kDa	O
protein	O
of	O
85	O
amino	O
acids	O
.	O

Database	O
searches	O
identified	O
these	O
genes	O
on	O
chromosome	O
19	O
,	O
which	O
could	O
account	O
for	O
the	O
cloned	O
imup-1	B
and	O
imup-2	B
transcripts	O
by	O
alternative	O
splicing	O
.	O

Southern	O
blot	O
analysis	O
of	O
digested	O
genomic	O
DNA	O
confirmed	O
that	O
both	O
transcripts	O
are	O
derived	O
from	O
a	O
single	O
locus	O
.	O

The	O
expressed	O
proteins	O
IMUP-1	B
and	O
IMUP-2	B
share	O
46	O
identical	O
N	O
-	O
terminal	O
amino	O
acids	O
,	O
whereas	O
the	O
C	O
-	O
termini	O
are	O
unrelated	O
.	O

Green	O
fluorescent	O
protein	O
-	O
fusions	O
of	O
both	O
IMUP-1	B
and	O
IMUP-2	B
accumulated	O
in	O
the	O
nucleus	O
of	O
HeLa	O
cells	O
.	O

The	O
C	O
-	O
terminus	O
of	O
IMUP-1	B
contains	O
a	O
bipartite	O
nuclear	O
localization	O
signal	O
,	O
the	O
deletion	O
of	O
which	O
impaired	O
nuclear	O
translocation	O
.	O

In	O
-	O
vitro	O
translated	O
proteins	O
bound	O
to	O
poly	O
(	O
rG	O
)	O
,	O
but	O
did	O
not	O
interact	O
with	O
single	O
-	O
stranded	O
DNA	O
or	O
double	O
-	O
stranded	O
DNA	O
.	O

The	O
nuclear	O
localization	O
of	O
IMUP-1	B
and	O
IMUP-2	B
as	O
well	O
as	O
the	O
upregulation	O
of	O
both	O
underlying	O
mRNAs	O
in	O
immortalized	O
cells	O
suggest	O
a	O
function	O
in	O
immortalization	O
.	O

Identification	O
of	O
a	O
novel	O
thioredoxin	B
-	O
related	O
transmembrane	O
protein	O
.	O

We	O
recently	O
identified	O
a	O
series	O
of	O
transforming	O
growth	O
factor	O
-	O
beta	O
-	O
responsive	O
genes	O
in	O
A549	O
human	O
adenocarcinoma	O
cell	O
line	O
by	O
a	O
gene	O
trap	O
screening	O
method	O
.	O

Here	O
we	O
report	O
the	O
molecular	O
cloning	O
and	O
characterization	O
of	O
one	O
of	O
these	O
genes	O
,	O
designated	O
TMX	B
,	O
that	O
encodes	O
a	O
novel	O
protein	O
of	O
280	O
amino	O
acid	O
residues	O
.	O

The	O
TMX	B
protein	O
possesses	O
an	O
N	O
-	O
terminal	O
signal	O
peptide	O
followed	O
by	O
one	O
thioredoxin	B
(	O
Trx	B
)	O
-like	O
domain	O
with	O
a	O
unique	O
active	O
site	O
sequence	O
,	O
Cys	O
-	O
Pro	O
-	O
Ala	O
-	O
Cys	O
,	O
and	O
a	O
potential	O
transmembrane	O
domain	O
.	O

There	O
are	O
putative	O
TMX	B
homologs	O
with	O
identical	O
active	O
site	O
sequences	O
in	O
the	O
Caenorhabditis	O
elegans	O
and	O
Drosophila	O
genomes	O
.	O

Using	O
recombinant	O
proteins	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
we	O
demonstrated	O
the	O
activity	O
of	O
the	O
Trx	B
domain	O
of	O
TMX	B
to	O
cleave	O
the	O
interchain	O
disulfide	O
bridges	O
in	O
insulin	B
in	O
vitro	O
.	O

The	O
TMX	B
transcript	O
is	O
widely	O
expressed	O
in	O
normal	O
human	O
tissues	O
,	O
and	O
subcellular	O
fractionation	O
and	O
immunostaining	O
for	O
an	O
epitope	O
-	O
tagged	O
TMX	B
protein	O
suggest	O
that	O
TMX	B
is	O
predominantly	O
localized	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
.	O

When	O
TMX	B
was	O
expressed	O
in	O
HEK293	O
cells	O
,	O
it	O
significantly	O
suppressed	O
the	O
apoptosis	O
induced	O
by	O
brefeldin	O
A	O
,	O
an	O
inhibitor	O
of	O
ER	O
-	O
Golgi	O
transport	O
.	O

This	O
activity	O
was	O
abolished	O
when	O
two	O
Cys	O
residues	O
in	O
the	O
active	O
site	O
sequence	O
were	O
mutated	O
to	O
Ser	O
,	O
suggesting	O
that	O
the	O
Trx	B
-	O
like	O
activity	O
of	O
TMX	B
may	O
help	O
relieve	O
ER	O
stress	O
caused	O
by	O
brefeldin	O
A.	O

A	O
new	O
spectrin	B
,	I
beta	I
IV	I
,	O
has	O
a	O
major	O
truncated	O
isoform	O
that	O
associates	O
with	O
promyelocytic	B
leukemia	I
protein	I
nuclear	O
bodies	O
and	O
the	O
nuclear	O
matrix	O
.	O

We	O
isolated	O
cDNAs	O
that	O
encode	O
a	O
77-kDa	O
peptide	O
similar	O
to	O
repeats	O
10	O
-	O
16	O
of	O
beta	O
-	O
spectrins	O
.	O

Its	O
gene	O
localizes	O
to	O
human	O
chromosome	O
19q13.13-q13.2	O
and	O
mouse	O
chromosome	O
7	O
,	O
at	O
7.5	O
centimorgans	O
.	O

A	O
289-kDa	O
isoform	O
,	O
similar	O
to	O
full	O
-	O
length	O
beta	O
-	O
spectrins	O
,	O
was	O
partially	O
assembled	O
from	O
sequences	O
in	O
the	O
human	O
genomic	O
DNA	O
data	O
base	O
and	O
completely	O
cloned	O
and	O
sequenced	O
.	O

RNA	O
transcripts	O
are	O
seen	O
predominantly	O
in	O
the	O
brain	O
,	O
and	O
Western	O
analysis	O
shows	O
a	O
major	O
peptide	O
that	O
migrates	O
as	O
a	O
72-kDa	O
band	O
.	O

This	O
new	O
gene	O
,	O
spectrin	B
betaIV	I
,	O
thus	O
encodes	O
a	O
full	O
-	O
length	O
minor	O
isoform	O
(	O
SpbetaIVSigma1	B
)	O
and	O
a	O
truncated	O
major	O
isoform	O
(	O
SpbetaIVSigma5	B
)	O
.	O

Immunostaining	O
of	O
cells	O
shows	O
a	O
micropunctate	O
pattern	O
in	O
the	O
cytoplasm	O
and	O
nucleus	O
.	O

In	O
mesenchymal	O
stem	O
cells	O
,	O
the	O
staining	O
concentrates	O
at	O
nuclear	O
dots	O
that	O
stain	O
positively	O
for	O
the	O
promyelocytic	B
leukemia	I
protein	I
(	O
PML	B
)	O
.	O

Expression	O
of	O
SpbetaIVSigma5	B
fused	O
to	O
green	O
fluorescence	O
protein	O
in	O
cells	O
produces	O
nuclear	O
dots	O
that	O
include	O
all	O
PML	B
bodies	O
,	O
which	O
double	O
in	O
number	O
in	O
transfected	O
cells	O
.	O

Deletion	O
analysis	O
shows	O
that	O
partial	O
repeats	O
10	O
and	O
16	O
of	O
SpbetaIVSigma5	B
are	O
necessary	O
for	O
nuclear	O
dot	O
formation	O
.	O

Immunostaining	O
of	O
whole	O
-	O
mount	O
nuclear	O
matrices	O
reveals	O
diffuse	O
positivity	O
with	O
accentuation	O
at	O
PML	B
bodies	O
.	O

Spectrin	B
betaIV	I
is	O
the	O
first	O
beta	O
-	O
spectrin	O
associated	O
with	O
a	O
subnuclear	O
structure	O
and	O
may	O
be	O
part	O
of	O
a	O
nuclear	O
scaffold	O
to	O
which	O
gene	O
regulatory	O
machinery	O
binds	O
.	O

Identification	O
and	O
characterization	O
of	O
a	O
human	O
mitochondrial	O
homologue	O
of	O
the	O
bacterial	O
co	O
-	O
chaperone	O
GrpE.	B
We	O
have	O
identified	O
a	O
novel	O
human	O
cDNA	O
with	O
a	O
predicted	O
protein	O
sequence	O
that	O
has	O
28	O
%	O
amino	O
acid	O
identity	O
with	O
the	O
E.	O
coli	O
Hsp70	O
co	O
-	O
chaperone	O
GrpE	B
and	O
designated	O
it	O
HMGE	B
.	O

Even	O
with	O
this	O
low	O
level	O
of	O
amino	O
acid	O
identity	O
the	O
human	O
sequence	O
could	O
be	O
efficiently	O
modelled	O
on	O
the	O
X	O
-	O
ray	O
structure	O
of	O
the	O
E.	O
coli	O
protein	O
,	O
suggesting	O
that	O
there	O
may	O
be	O
significant	O
functional	O
conservation	O
.	O

Indeed	O
,	O
HMGE	B
expressed	O
in	O
E.	O
coli	O
as	O
a	O
GST	O
fusion	O
protein	O
co	O
-	O
purified	O
with	O
the	O
E.	O
coli	O
Hsp70	O
protein	O
DnaK	O
in	O
the	O
absence	O
of	O
ATP	O
.	O

DnaK	O
could	O
be	O
released	O
from	O
the	O
GST	O
-	O
HMGE	B
with	O
a	O
Mg	O
-	O
ATP	O
wash	O
.	O

Subcellular	O
fractionation	O
and	O
immunocytochemistry	O
studies	O
using	O
antisera	O
raized	O
against	O
HMGE	B
show	O
that	O
it	O
is	O
a	O
mitochondrial	O
protein	O
.	O

In	O
contrast	O
to	O
studies	O
of	O
rat	O
GrpE	B
,	O
however	O
,	O
HMGE	B
also	O
appears	O
to	O
bind	O
the	O
constitutive	O
cytosolic	O
Hsp70	O
,	O
Hsc70	B
,	O
in	O
addition	O
to	O
mitochondrial	O
Hsp70	O
,	O
Mt	B
-	I
Hsp70	I
.	O

We	O
have	O
previously	O
shown	O
that	O
Hsc70	B
nucleotide	O
-	O
exchange	O
is	O
rate	O
limiting	O
in	O
the	O
presence	O
of	O
the	O
DnaJ	O
-	O
protein	O
,	O
HSJ1b	B
.	O

However	O
,	O
HMGE	B
was	O
found	O
to	O
inhibit	O
the	O
HSJ1b	B
-	O
enhanced	O
Hsc70	B
ATPase	O
activity	O
and	O
may	O
mediate	O
this	O
inhibition	O
by	O
binding	O
the	O
DnaJ	O
-	O
protein	O
,	O
HSJ1b	B
.	O

This	O
is	O
the	O
first	O
description	O
of	O
a	O
direct	O
interaction	O
between	O
a	O
DnaJ	O
protein	O
and	O
GrpE	B
-	O
like	O
protein	O
.	O

These	O
studies	O
suggest	O
that	O
the	O
structure	O
of	O
GrpE	B
has	O
been	O
conserved	O
throughout	O
evolution	O
and	O
that	O
the	O
conserved	O
structure	O
can	O
interact	O
with	O
several	O
forms	O
of	O
Hsp70	O
,	O
but	O
that	O
HMGE	B
can	O
not	O
form	O
part	O
of	O
the	O
reaction	O
cycle	O
for	O
cytosolic	O
Hsc70	B
.	O

Paip1	B
interacts	O
with	O
poly	B
(	I
A	I
)	I
binding	I
protein	I
through	O
two	O
independent	O
binding	O
motifs	O
.	O

The	O
3	O
'	O
poly	O
(	O
A	O
)	O
tail	O
of	O
eukaryotic	O
mRNAs	O
plays	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
translation	O
.	O

The	O
poly	B
(	I
A	I
)	I
binding	I
protein	I
(	O
PABP	B
)	O
interacts	O
with	O
eukaryotic	B
initiation	I
factor	I
4	I
G	I
(	O
eIF4	B
G	I
)	O
,	O
a	O
component	O
of	O
the	O
eIF4F	B
complex	O
,	O
which	O
binds	O
to	O
the	O
5	O
'	O
cap	O
structure	O
.	O

The	O
PABP	B
-	O
eIF4	B
G	I
interaction	O
brings	O
about	O
the	O
circularization	O
of	O
the	O
mRNA	O
by	O
joining	O
its	O
5	O
'	O
and	O
3	O
'	O
termini	O
,	O
thereby	O
stimulating	O
mRNA	O
translation	O
.	O

The	O
activity	O
of	O
PABP	B
is	O
regulated	O
by	O
two	O
interacting	O
proteins	O
,	O
Paip1	B
and	O
Paip2	B
.	O

To	O
study	O
the	O
mechanism	O
of	O
the	O
Paip1-PABP	B
interaction	O
,	O
far	O
-	O
Western	O
,	O
glutathione	O
S	O
-	O
transferase	O
pull	O
-	O
down	O
,	O
and	O
surface	O
plasmon	O
resonance	O
experiments	O
were	O
performed	O
.	O

Paip1	B
contains	O
two	O
binding	O
sites	O
for	O
PABP	B
,	O
PAM1	O
and	O
PAM2	O
(	O
for	O
PABP	B
-	O
interacting	O
motifs	O
1	O
and	O
2	O
)	O
.	O

PAM2	O
consists	O
of	O
a	O
15-amino	O
-	O
acid	O
stretch	O
residing	O
in	O
the	O
N	O
terminus	O
,	O
and	O
PAM1	O
encompasses	O
a	O
larger	O
C	O
-	O
terminal	O
acidic	O
-	O
amino	O
-	O
acid	O
-	O
rich	O
region	O
.	O

PABP	B
also	O
contains	O
two	O
Paip1	B
binding	O
sites	O
,	O
one	O
located	O
in	O
RNA	O
recognition	O
motifs	O
1	O
and	O
2	O
and	O
the	O
other	O
located	O
in	O
the	O
C	O
-	O
terminal	O
domain	O
.	O

Paip1	B
binds	O
to	O
PABP	B
with	O
a	O
1:1	O
stoichiometry	O
and	O
an	O
apparent	O
K	O
(	O
d	O
)	O
of	O
1.9	O
nM.	O

Poly	B
(	I
ADP	I
-	I
ribose	I
)	I
polymerase-1	I
cleavage	O
during	O
apoptosis	O
:	O
an	O
update	O
.	O

Poly	O
(	O
ADP	O
-	O
ribosylation	O
)	O
is	O
a	O
post	O
-	O
translational	O
modification	O
of	O
proteins	O
playing	O
a	O
crucial	O
role	O
in	O
many	O
processes	O
,	O
including	O
DNA	O
repair	O
and	O
cell	O
death	O
.	O

The	O
best	O
known	O
poly	O
(	O
ADP	O
-	O
ribosylating	O
)	O
enzyme	O
,	O
PARP-1	B
,	O
is	O
a	O
DNA	O
nick	O
sensor	O
and	O
uses	O
betaNAD	O
(	O
+	O
)	O
to	O
form	O
polymers	O
of	O
ADP	O
-	O
ribose	O
which	O
are	O
further	O
bound	O
to	O
nuclear	O
protein	O
acceptors	O
.	O

To	O
strictly	O
regulate	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
turnover	O
,	O
its	O
degradation	O
is	O
assured	O
by	O
the	O
enzyme	O
poly	B
(	I
ADP	I
-	I
ribose	I
)	I
glycohydrolase	I
(	O
PARG	B
)	O
.	O

During	O
apoptosis	O
,	O
PARP-1	B
plays	O
two	O
opposite	O
roles	O
:	O
its	O
stimulation	O
leads	O
to	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
synthesis	O
,	O
whereas	O
caspases	O
cause	O
PARP-1	B
cleavage	O
and	O
inactivation	O
.	O

PARP-1	B
proteolysis	O
produces	O
an	O
89	O
kDa	O
C	O
-	O
terminal	O
fragment	O
,	O
with	O
a	O
reduced	O
catalytic	O
activity	O
,	O
and	O
a	O
24	O
kDa	O
N	O
-	O
terminal	O
peptide	O
,	O
which	O
retains	O
the	O
DNA	O
binding	O
domains	O
.	O

The	O
fate	O
and	O
the	O
possible	O
role	O
of	O
these	O
fragments	O
during	O
apoptosis	O
will	O
be	O
discussed	O
.	O

Inhibition	O
of	O
poly	B
(	I
ADP	I
-	I
ribose	I
)	I
polymerase	I
activation	O
attenuates	O
beta	O
-	O
lapachone	O
-	O
induced	O
necrotic	O
cell	O
death	O
in	O
human	O
osteosarcoma	O
cells	O
.	O

beta	O
-	O
Lapachone	O
,	O
a	O
novel	O
anticancer	O
drug	O
,	O
induces	O
various	O
human	O
carcinoma	O
cells	O
to	O
undergo	O
apoptotic	O
cell	O
death	O
.	O

However	O
,	O
we	O
report	O
here	O
that	O
,	O
in	O
human	O
osteocarcinoma	O
(	O
U2-OS	O
)	O
cells	O
,	O
beta	O
-	O
lapachone	O
induces	O
necrosis	O
rather	O
than	O
apoptosis	O
.	O

beta	O
-	O
Lapachone	O
-	O
induced	O
necrotic	O
cell	O
death	O
in	O
U2-OS	O
cells	O
was	O
characterized	O
by	O
propidium	O
iodide	O
uptake	O
,	O
cytochrome	B
c	I
release	O
,	O
a	O
decreased	O
mitochondrial	O
membrane	O
potential	O
,	O
and	O
ATP	O
depletion	O
.	O

The	O
mitochondrial	O
potential	O
transition	O
(	O
MPT	O
)	O
,	O
including	O
the	O
reduction	O
of	O
the	O
mitochondrial	O
transmembrane	O
potential	O
and	O
the	O
release	O
of	O
mitochondrial	O
cytochrome	B
c	I
,	O
occurred	O
in	O
beta	O
-	O
lapachone	O
-	O
treated	O
cells	O
;	O
cotreatment	O
of	O
these	O
cells	O
with	O
cyclosporin	O
A	O
,	O
an	O
inhibitor	O
of	O
MPT	O
pore	O
,	O
failed	O
to	O
prevent	O
necrotic	O
cell	O
death	O
.	O

This	O
indicates	O
that	O
the	O
MPT	O
transition	O
does	O
not	O
play	O
a	O
crucial	O
role	O
in	O
this	O
process	O
.	O

Furthermore	O
,	O
beta	O
-	O
lapachone	O
-	O
induced	O
necrosis	O
was	O
independent	O
of	O
oxidative	O
stress	O
and	O
caspase	O
activation	O
.	O

However	O
,	O
excessive	O
poly	B
(	I
ADP	I
-	I
ribose	I
)	I
polymerase	I
(	O
PARP	B
)	O
activation	O
and	O
subsequent	O
depletion	O
of	O
intracellular	O
NAD	O
(	O
+	O
)	O
and	O
ATP	O
were	O
seen	O
in	O
beta	O
-	O
lapachone	O
-	O
treated	O
U2-OS	O
cells	O
.	O

Cotreatment	O
with	O
a	O
PARP	B
inhibitor	O
,	O
3-aminobenzamide	O
,	O
decreased	O
beta	O
-	O
lapachone	O
-	O
induced	O
PARP	B
activation	O
and	O
provided	O
significant	O
protection	O
from	O
necrosis	O
by	O
preventing	O
depletion	O
of	O
intracellular	O
NAD	O
(	O
+	O
)	O
and	O
ATP	O
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
PARP	B
plays	O
an	O
important	O
role	O
in	O
the	O
signaling	O
pathway	O
for	O
beta	O
-	O
lapachone	O
-	O
induced	O
necrosis	O
in	O
U2-OS	O
cells	O
.	O

Nociceptive	O
sensitization	O
by	O
the	O
secretory	O
protein	O
Bv8	O
.	O

1	O
The	O
small	O
protein	O
Bv8	O
,	O
isolated	O
from	O
amphibian	O
skin	O
,	O
belongs	O
to	O
a	O
novel	O
family	O
of	O
secretory	O
proteins	O
(	O
Bv8-Prokineticin	O
family	O
,	O
SWISS	O
-	O
PROT	O
:	O
Q9PW66	O
)	O
whose	O
orthologues	O
have	O
been	O
conserved	O
throughout	O
evolution	O
,	O
from	O
invertebrates	O
to	O
humans	O
.	O

2	O
When	O
injected	O
intravenously	O
or	O
subcutaneously	O
(	O
from	O
0.06	O
to	O
500	O
pmol	O
kg	O
(	O
-1	O
)	O
)	O
or	O
intrathecally	O
(	O
from	O
6	O
fmol	O
to	O
250	O
pmol	O
)	O
in	O
rats	O
,	O
Bv8	O
produced	O
an	O
intense	O
systemic	O
nociceptive	O
sensitization	O
to	O
mechanical	O
and	O
thermal	O
stimuli	O
applied	O
to	O
the	O
tail	O
and	O
paws	O
.	O

3	O
Topically	O
delivered	O
into	O
one	O
rat	O
paw	O
,	O
50	O
fmol	O
of	O
Bv8	O
decreased	O
by	O
50	O
%	O
the	O
nociceptive	O
threshold	O
to	O
pressure	O
in	O
the	O
injected	O
paw	O
without	O
affecting	O
the	O
threshold	O
in	O
the	O
contralateral	O
paw	O
.	O

4	O
The	O
two	O
G	O
-	O
protein	O
coupled	O
prokineticin	O
receptors	O
,	O
PK	B
-	I
R1	I
and	O
PK	B
-	I
R2	I
,	O
were	O
expressed	O
in	O
rat	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
and	O
in	O
dorsal	O
quadrants	O
of	O
spinal	O
cord	O
(	O
DSC	O
)	O
and	O
bound	O
Bv8	O
and	O
the	O
mammalian	O
orthologue	O
,	O
EG	B
-	I
VEGF	I
,	O
with	O
high	O
affinity	O
.	O

In	O
DSC	O
,	O
PK	B
-	I
R1	I
was	O
more	O
abundant	O
than	O
PK	B
-	I
R2	I
,	O
whereas	O
both	O
receptors	O
were	O
equally	O
expressed	O
in	O
DRG	O
.	O

IC	O
(	O
50	O
)	O
of	O
Bv8	O
and	O
EG	B
-	I
VEGF	I
to	O
inhibit	O
[	O
(	O
125	O
)	O
I	O
]	O
-Bv8	O
binding	O
to	O
rat	O
DRG	O
and	O
DSC	O
were	O
4.1+	O
/	O
-0.4	O
nM	O
Bv8	O
and	O
76.4+	O
/	O
-7.6	O
nM	O
EG	B
-	I
VEGF	I
,	O
in	O
DRG	O
;	O
7.3+	O
/	O
-0.9	O
nM	O
Bv8	O
and	O
330+	O
/	O
-41	O
nM	O
EG	B
-	I
VEGF	I
,	O
in	O
DSC	O
.	O

5	O
In	O
the	O
small	O
diameter	O
neurons	O
(	O
<	O
30	O
microm	O
)	O
of	O
rat	O
DRG	O
cultures	O
,	O
Bv8	O
concentrations	O
,	O
ranging	O
from	O
0.2	O
to	O
10	O
nM	O
,	O
raised	O
[	O
Ca	O
(	O
2+	O
)	O
]	O
(	O
i	O
)	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

6	O
These	O
data	O
suggest	O
that	O
Bv8	O
,	O
through	O
binding	O
to	O
PK	O
receptors	O
of	O
DSC	O
and	O
primary	O
sensitive	O
neurons	O
,	O
results	O
in	O
intense	O
sensitization	O
of	O
peripheral	O
nociceptors	O
to	O
thermal	O
and	O
mechanical	O
stimuli	O
.	O

US11	O
of	O
herpes	O
simplex	O
virus	O
type	O
1	O
interacts	O
with	O
HIPK2	B
and	O
antagonizes	O
HIPK2-induced	B
cell	O
growth	O
arrest	O
.	O

Homeodomain	B
-	I
interacting	I
protein	I
kinase	I
2	I
(	O
HIPK2	B
)	O
is	O
a	O
nuclear	O
serine	O
/	O
threonine	O
kinase	O
of	O
the	O
subfamily	O
of	O
dual	O
-	O
specificity	O
Yak1-related	O
kinase	O
proteins	O
.	O

HIPK2	B
was	O
first	O
described	O
as	O
a	O
homeodomain	O
-	O
interacting	O
protein	O
kinase	O
acting	O
as	O
a	O
corepressor	O
for	O
homeodomain	O
transcription	O
factors	O
.	O

More	O
recently	O
,	O
it	O
was	O
reported	O
that	O
HIPK2	B
plays	O
a	O
role	O
in	O
p53-mediated	B
cellular	O
apoptosis	O
and	O
could	O
also	O
participate	O
in	O
the	O
regulation	O
of	O
the	O
cell	O
cycle	O
.	O

US11	O
protein	O
of	O
herpes	O
simplex	O
virus	O
type	O
1	O
is	O
a	O
multifunctional	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
several	O
processes	O
related	O
to	O
the	O
survival	O
of	O
cells	O
submitted	O
to	O
environmental	O
stresses	O
by	O
mechanisms	O
that	O
are	O
not	O
fully	O
elucidated	O
.	O

In	O
an	O
attempt	O
to	O
better	O
understand	O
the	O
multiple	O
functions	O
of	O
US11	O
,	O
we	O
identified	O
cellular	O
binding	O
partners	O
of	O
this	O
protein	O
by	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O

We	O
report	O
that	O
US11	O
interacts	O
with	O
HIPK2	B
through	O
the	O
PEST	O
domain	O
of	O
HIPK2	B
and	O
that	O
this	O
interaction	O
occurs	O
also	O
in	O
human	O
cells	O
.	O

This	O
interaction	O
modifies	O
the	O
subcellular	O
distribution	O
of	O
HIPK2	B
and	O
protects	O
the	O
cell	O
against	O
the	O
HIPK2-induced	B
cell	O
growth	O
arrest	O
.	O

Physical	O
and	O
functional	O
interactions	O
between	O
Daxx	B
and	O
TSG101	B
.	O

Daxx	B
has	O
been	O
reported	O
to	O
mediate	O
the	O
Fas	B
/	O
JNK	B
-	O
dependent	O
signals	O
in	O
the	O
cytoplasm	O
.	O

However	O
,	O
several	O
evidences	O
have	O
suggested	O
that	O
Daxx	B
is	O
located	O
mainly	O
in	O
the	O
nucleus	O
and	O
functions	O
as	O
a	O
transcriptional	O
regulator	O
.	O

Recently	O
,	O
we	O
identified	O
DMAP1	B
,	O
a	O
TSG101-interacting	B
protein	O
as	O
a	O
Daxx	B
binding	O
partner	O
by	O
yeast	O
two	O
-	O
hybrid	O
screening	O
.	O

TSG101	B
has	O
been	O
shown	O
to	O
act	O
as	O
transcriptional	O
co	O
-	O
repressor	O
of	O
nuclear	O
hormone	O
receptors	O
.	O

Here	O
we	O
examined	O
whether	O
TSG101also	O
interacts	O
with	O
Daxx	B
directly	O
.	O

The	O
association	O
of	O
Daxx	B
and	O
TSG101	B
was	O
confirmed	O
using	O
co	O
-	O
expressed	O
tagged	O
proteins	O
.	O

The	O
interaction	O
regions	O
in	O
both	O
proteins	O
were	O
also	O
mapped	O
,	O
and	O
the	O
cellular	O
localization	O
of	O
the	O
interaction	O
was	O
examined	O
.	O

TSG101	B
formed	O
a	O
complex	O
with	O
Daxx	B
through	O
its	O
coiled	O
-	O
coil	O
domain	O
and	O
co	O
-	O
localized	O
in	O
the	O
nucleus	O
.	O

Furthermore	O
,	O
TSG101	B
enhanced	O
Daxx	B
-	O
mediated	O
repression	O
of	O
glucocorticoid	B
receptor	I
transcriptional	O
activity	O
.	O

These	O
results	O
provide	O
the	O
novel	O
molecular	O
interactions	O
between	O
Daxx	B
and	O
TSG101	B
,	O
which	O
establish	O
an	O
efficient	O
repressive	O
transcription	O
complex	O
in	O
the	O
nucleus	O
.	O

Statherin	B
:	O
a	O
major	O
boundary	O
lubricant	O
of	O
human	O
saliva	O
.	O

The	O
lubricating	O
properties	O
of	O
human	O
submandibular	O
-	O
sublingual	O
salivary	O
fractions	O
were	O
examined	O
using	O
a	O
servohydraulic	O
model	O
of	O
mandibular	O
movement	O
.	O

Fractions	O
containing	O
statherin	B
exhibited	O
a	O
strong	O
tendency	O
to	O
boundary	O
lubrication	O
.	O

The	O
lubricity	O
of	O
purified	O
statherin	B
was	O
confirmed	O
and	O
compared	O
to	O
the	O
amphipathic	O
molecules	O
gramacidin	O
S	O
and	O
sodium	O
dodecyl	O
sulfate	O
.	O

Contact	O
angle	O
measurements	O
of	O
statherin	B
paralleled	O
the	O
other	O
amphipathic	O
molecules	O
.	O

The	O
helical	O
content	O
of	O
statherin	B
increased	O
in	O
trifluoroethanol	O
indicating	O
the	O
presence	O
of	O
amphipathic	O
helical	O
regions	O
.	O

CD	O
studies	O
and	O
hydrophobic	O
moment	O
calculations	O
indicated	O
that	O
statherin	B
adopts	O
an	O
amphipathic	O
helical	O
conformation	O
at	O
the	O
N	O
-	O
terminus	O
.	O

An	O
energy	O
-	O
minimized	O
model	O
of	O
the	O
polar	O
N	O
-	O
terminal	O
residues	O
1	O
-	O
15	O
suggested	O
that	O
this	O
domain	O
could	O
be	O
positioned	O
in	O
space	O
to	O
interact	O
with	O
a	O
hydroxyapatite	O
substrate	O
.	O

These	O
data	O
imply	O
that	O
under	O
appropriate	O
conditions	O
statherin	B
may	O
display	O
an	O
amphipathic	O
nature	O
which	O
enables	O
it	O
to	O
function	O
as	O
a	O
boundary	O
lubricant	O
on	O
enamel	O
.	O

A	O
novel	O
IL-1	B
receptor	O
,	O
cloned	O
from	O
B	O
cells	O
by	O
mammalian	O
expression	O
,	O
is	O
expressed	O
in	O
many	O
cell	O
types	O
.	O

cDNA	O
clones	O
corresponding	O
to	O
an	O
Mr	O
approximately	O
80,000	O
receptor	O
(	B
type	I
I	I
receptor	I
)	I
for	I
interleukin-1	I
(	I
IL-1	I
)	I
have	O
been	O
isolated	O
previously	O
by	O
mammalian	O
expression	O
.	O

Here	O
,	O
we	O
report	O
the	O
use	O
of	O
an	O
improved	O
expression	O
cloning	O
method	O
to	O
isolate	O
human	O
and	O
murine	O
cDNA	O
clones	O
encoding	O
a	B
second	I
type	I
(	I
Mr	I
approximately	I
60,000	I
)	I
of	I
IL-1	I
receptor	I
(	I
type	I
II	I
receptor	I
)	I
.	O

The	O
mature	O
type	B
II	I
IL-1	I
receptor	I
consists	O
of	O
(	O
i	O
)	O
a	O
ligand	O
binding	O
portion	O
comprised	O
of	O
three	O
immunoglobulin	O
-	O
like	O
domains	O
;	O
(	O
ii	O
)	O
a	O
single	O
transmembrane	O
region	O
;	O
and	O
(	O
iii	O
)	O
a	O
short	O
cytoplasmic	O
domain	O
of	O
29	O
amino	O
acids	O
.	O

This	O
last	O
contrasts	O
with	O
the	O
approximately	O
215	O
amino	O
acid	O
cytoplasmic	O
domain	O
of	O
the	O
type	O
I	O
receptor	O
,	O
and	O
suggests	O
that	O
the	O
two	O
IL-1	B
receptors	O
may	O
interact	O
with	O
different	O
signal	O
transduction	O
pathways	O
.	O

The	O
type	O
II	O
receptor	O
is	O
expressed	O
in	O
a	O
number	O
of	O
different	O
tissues	O
,	O
including	O
both	O
B	O
and	O
T	O
lymphocytes	O
,	O
and	O
can	O
be	O
induced	O
in	O
several	O
cell	O
types	O
by	O
treatment	O
with	O
phorbol	O
ester	O
.	O

Both	O
IL-1	B
receptors	O
appear	O
to	O
be	O
well	O
conserved	O
in	O
evolution	O
,	O
and	O
map	O
to	O
the	O
same	O
chromosomal	O
location	O
.	O

Like	O
the	O
type	O
I	O
receptor	O
,	O
the	O
human	O
type	B
II	I
IL-1	I
receptor	I
can	O
bind	O
all	O
three	O
forms	O
of	O
IL-1	B
(	O
IL-1	B
alpha	I
,	O
IL-1	B
beta	I
and	O
IL-1ra	B
)	O
.	O

Vaccinia	O
virus	O
contains	O
an	O
open	O
reading	O
frame	O
bearing	O
strong	O
resemblance	O
to	O
the	O
type	B
II	I
IL-1	I
receptor	I
.	O

A	O
1.1-Mb	O
transcript	O
map	O
of	O
the	O
hereditary	O
hemochromatosis	O
locus	O
.	O

In	O
the	O
process	O
of	O
positionally	O
cloning	O
a	O
candidate	O
gene	O
responsible	O
for	O
hereditary	O
hemochromatosis	O
(	O
HH	O
)	O
,	O
we	O
constructed	O
a	O
1.1-Mb	O
transcript	O
map	O
of	O
the	O
region	O
of	O
human	O
chromosome	O
6p	O
that	O
lies	O
4.5	O
Mb	O
telomeric	O
to	O
HLA	B
-	I
A.	I
A	O
combination	O
of	O
three	O
gene	O
-	O
finding	O
techniques	O
,	O
direct	O
cDNA	O
selection	O
,	O
exon	O
trapping	O
,	O
and	O
sample	O
sequencing	O
,	O
were	O
used	O
initially	O
for	O
a	O
saturation	O
screening	O
of	O
the	O
1.1-Mb	O
region	O
for	O
expressed	O
sequence	O
fragments	O
.	O

As	O
genetic	O
analysis	O
further	O
narrowed	O
the	O
HH	O
candidate	O
locus	O
,	O
we	O
sequenced	O
completely	O
0.25	O
Mb	O
of	O
genomic	O
DNA	O
as	O
a	O
final	O
measure	O
to	O
identify	O
all	O
genes	O
.	O

Besides	O
the	O
novel	O
MHC	O
class	O
1-like	O
HH	O
candidate	O
gene	O
HLA	B
-	I
H	I
,	O
we	O
identified	O
a	O
family	O
of	O
five	O
butyrophilin	O
-	O
related	O
sequences	O
,	O
two	O
genes	O
with	O
structural	O
similarity	O
to	O
a	O
type	O
1	O
sodium	O
phosphate	O
transporter	O
,	O
12	O
novel	O
histone	O
genes	O
,	O
and	O
a	O
gene	O
we	O
named	O
RoRet	B
based	O
on	O
its	O
strong	O
similarity	O
to	O
the	O
52-kD	O
Ro	O
/	O
SSA	B
lupus	O
and	O
Sjogren	O
's	O
syndrome	O
auto	O
-	O
antigen	O
and	O
the	O
RET	B
finger	I
protein	I
.	O

Several	O
members	O
of	O
the	O
butyrophilin	O
family	O
and	O
the	O
RoRet	B
gene	O
share	O
an	O
exon	O
of	O
common	O
evolutionary	O
origin	O
called	O
B30	O
-	O
2	O
.	O

The	O
B30	O
-	O
2	O
exon	O
was	O
originally	O
isolated	O
from	O
the	O
HLA	O
class	O
1	O
region	O
,	O
yet	O
has	O
apparently	O
""""	O
shuffled	O
""""	O
into	O
several	O
genes	O
along	O
the	O
chromosome	O
telomeric	O
to	O
the	O
MHC	O
.	O

The	O
conservation	O
of	O
the	O
B30	O
-	O
2	O
exon	O
in	O
several	O
novel	O
genes	O
and	O
the	O
previously	O
described	O
amino	O
acid	O
homology	O
of	O
HLA	B
-	I
H	I
to	O
MHC	O
class	O
1	O
molecules	O
provide	O
further	O
support	O
that	O
this	O
gene	O
-	O
rich	O
region	O
of	O
6p21.3	O
is	O
related	O
to	O
the	O
MHC	O
.	O

Finally	O
,	O
we	O
performed	O
an	O
analysis	O
of	O
the	O
four	O
approaches	O
for	O
gene	O
finding	O
and	O
conclude	O
that	O
direct	O
selection	O
provides	O
the	O
most	O
effective	O
probes	O
for	O
cDNA	O
screening	O
,	O
and	O
that	O
as	O
much	O
as	O
30	O
%	O
of	O
ESTs	O
in	O
this	O
1.1-Mb	O
region	O
may	O
be	O
derived	O
from	O
noncoding	O
genomic	O
DNA	O
.	O

Mutations	O
in	O
PROP1	B
cause	O
familial	O
combined	O
pituitary	O
hormone	O
deficiency	O
.	O

Combined	O
pituitary	O
hormone	O
deficiency	O
(	O
CPHD	O
)	O
in	O
man	O
denotes	O
impaired	O
production	O
of	O
growth	B
hormone	I
(	O
GH	B
)	O
and	O
one	O
or	O
more	O
of	O
the	O
other	O
five	O
anterior	O
pituitary	O
hormones	O
.	O

Mutations	O
of	O
the	O
pituitary	O
transcription	O
factor	O
gene	O
POU1F1	B
(	O
the	O
human	B
homologue	I
of	I
mouse	I
Pit1	I
)	O
are	O
responsible	O
for	O
deficiencies	O
of	O
GH	B
,	O
prolactin	B
and	O
thyroid	O
stimulating	O
hormone	O
(	O
TSH	O
)	O
in	O
Snell	O
and	O
Jackson	O
dwarf	O
mice	O
and	O
in	O
man	O
,	O
while	O
the	O
production	O
of	O
adrenocorticotrophic	O
hormone	O
(	O
ACTH	O
)	O
,	O
luteinizing	O
hormone	O
(	O
LH	O
)	O
and	O
follicle	O
stimulating	O
hormone	O
(	O
FSH	O
)	O
is	O
preserved	O
.	O

The	O
Ames	O
dwarf	O
(	O
df	O
)	O
mouse	O
displays	O
a	O
similar	O
phenotype	O
,	O
and	O
appears	O
to	O
be	O
epistatic	O
to	O
Snell	O
and	O
Jackson	O
dwarfism	O
.	O

We	O
have	O
recently	O
positionally	O
cloned	O
the	O
putative	O
Ames	O
dwarf	O
gene	O
Prop1	B
,	O
which	O
encodes	O
a	O
paired	O
-	O
like	O
homeodomain	O
protein	O
that	O
is	O
expressed	O
specifically	O
in	O
embryonic	O
pituitary	O
and	O
is	O
necessary	O
for	O
Pit1	B
expression	O
.	O

In	O
this	O
report	O
,	O
we	O
have	O
identified	O
four	O
CPHD	O
families	O
with	O
homozygosity	O
or	O
compound	O
heterozygosity	O
for	O
inactivating	O
mutations	O
of	O
PROP1	B
.	O

These	O
mutations	O
in	O
the	O
human	O
PROP1	B
gene	O
result	O
in	O
a	O
gene	O
product	O
with	O
reduced	O
DNA	O
-	O
binding	O
and	O
transcriptional	O
activation	O
ability	O
in	O
comparison	O
to	O
the	O
product	O
of	O
the	O
murine	O
df	O
mutation	O
.	O

In	O
contrast	O
to	O
individuals	O
with	O
POU1F1	B
mutations	O
,	O
those	O
with	O
PROP1	B
mutations	O
can	O
not	O
produce	O
LH	O
and	O
FSH	O
at	O
a	O
sufficient	O
level	O
and	O
do	O
not	O
enter	O
puberty	O
spontaneously	O
.	O

Our	O
results	O
identify	O
a	O
major	O
cause	O
of	O
CPHD	O
in	O
humans	O
and	O
suggest	O
a	O
direct	O
or	O
indirect	O
role	O
for	O
PROP1	B
in	O
the	O
ontogenesis	O
of	O
pituitary	O
gonadotropes	O
,	O
as	O
well	O
as	O
somatotropes	O
,	O
lactotropes	O
and	O
caudomedial	O
thyrotropes	O
.	O

Discovery	O
of	O
three	O
novel	O
G	O
-	O
protein	O
-	O
coupled	O
receptor	O
genes	O
.	O

We	O
report	O
here	O
the	O
molecular	O
cloning	O
,	O
tissue	O
distribution	O
,	O
and	O
chromosomal	O
localization	O
of	O
novel	O
genes	O
encoding	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
(	O
GPCRs	O
)	O
.	O

A	O
search	O
of	O
a	O
mouse	O
database	O
of	O
expressed	O
sequence	O
tags	O
revealed	O
an	O
EST	O
partially	O
encoding	O
a	O
GPCR	O
,	O
which	O
was	O
used	O
to	O
screen	O
a	O
mouse	O
genomic	O
library	O
to	O
obtain	O
the	O
translational	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
.	O

The	O
resultant	O
clone	O
,	O
GPR27	B
,	O
contained	O
an	O
intronless	O
ORF	O
,	O
encoding	O
a	O
receptor	O
of	O
379	O
amino	O
acids	O
.	O

In	O
an	O
alternate	O
strategy	O
,	O
human	O
genomic	O
DNA	O
was	O
subjected	O
to	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
amplification	O
,	O
using	O
degenerate	O
oligonucleotides	O
based	O
on	O
GPR1	B
.	O

Two	O
PCR	O
products	O
partially	O
encoding	O
GPCRs	O
were	O
isolated	O
and	O
used	O
to	O
screen	O
a	O
genomic	O
library	O
to	O
obtain	O
the	O
translational	O
ORF	O
.	O

One	O
of	O
the	O
resultant	O
clones	O
,	O
GPR30	B
,	O
contained	O
an	O
intronless	O
ORF	O
encoding	O
a	O
receptor	O
of	O
375	O
amino	O
acids	O
.	O

The	O
other	O
clone	O
,	O
GPR35	B
,	O
also	O
contained	O
an	O
intronless	O
ORF	O
encoding	O
a	O
receptor	O
of	O
309	O
amino	O
acids	O
.	O

Transcripts	O
corresponding	O
to	O
GPR27	B
and	O
GPR30	B
were	O
detected	O
in	O
several	O
areas	O
of	O
human	O
and	O
rat	O
CNS	O
,	O
While	O
GPR35	B
expression	O
was	O
detected	O
only	O
in	O
the	O
rat	O
intestine	O
.	O

Through	O
fluorescence	O
in	O
situ	O
hybridization	O
analysis	O
the	O
gene	O
encoding	O
GPR30	B
was	O
localized	O
to	O
chromosome	O
7p22	O
and	O
GPR35	B
to	O
chromosome	O
2q37.3	O
.	O

New	O
eukaryotic	O
semaphorins	O
with	O
close	O
homology	O
to	O
semaphorins	O
of	O
DNA	O
viruses	O
.	O

Semaphorins	O
were	O
initially	O
described	O
as	O
a	O
family	O
of	O
repulsive	O
guidance	O
molecules	O
in	O
embryonal	O
development	O
.	O

Their	O
basic	O
structure	O
consists	O
of	O
an	O
N	O
-	O
terminal	O
signal	O
sequence	O
,	O
the	O
defining	O
semaphorin	O
domain	O
ofapproximately	O
500	O
amino	O
acids	O
,	O
an	O
Ig	O
-	O
like	O
domain	O
,	O
and	O
a	O
variable	O
carboxy	O
-	O
terminus	O
.	O

We	O
recently	O
described	O
a	O
viral	O
semaphorin	O
homologue	O
encoded	O
by	O
the	O
alcelaphine	O
herpesvirus	O
type	O
1	O
.	O

Less	O
conserved	O
,	O
truncated	O
homologues	O
were	O
also	O
identified	O
in	O
poxviruses	O
.	O

Here	O
we	O
describe	O
new	O
human	O
and	O
murine	O
semaphorin	O
homologues	O
.	O

The	O
respective	O
genes	O
were	O
cloned	O
and	O
sequenced	O
,	O
and	O
they	O
were	O
termed	O
H	B
-	I
Sema	I
-	I
L	I
and	O
M	O
-	O
Sema	O
-	O
L	O
(	O
HGMW	O
-	O
approved	O
symbols	O
SEMAL	B
and	O
Semal	B
,	O
respectively	O
)	O
.	O

A	O
multiply	O
spliced	O
mRNA	O
of	O
3.2	O
kb	O
is	O
expressed	O
in	O
human	O
placenta	O
,	O
spleen	O
,	O
thymus	O
,	O
and	O
gonadal	O
tissue	O
.	O

H	B
-	I
Sema	I
-	I
L	I
maps	O
to	O
chromosome	O
15q22.3-q23	O
and	O
M	O
-	O
Sema	O
-	O
L	O
to	O
the	O
homologous	O
locus	O
9A3.3-B	O
in	O
the	O
mouse	O
genome	O
.	O

The	O
expression	O
patterns	O
and	O
the	O
presence	O
of	O
related	O
genes	O
in	O
large	O
DNA	O
viruses	O
suggest	O
that	O
this	O
new	O
semaphorin	O
has	O
a	O
relevant	O
function	O
in	O
the	O
immune	O
system	O
.	O

We	O
describe	O
an	O
experimental	O
approach	O
to	O
the	O
use	O
of	O
genetics	O
to	O
study	O
muscle	O
contraction	O
in	O
Drosophila	O
melanogaster	O
.	O

Mutations	O
induced	O
by	O
in	O
vitro	O
mutagenesis	O
are	O
inserted	O
into	O
the	O
genome	O
of	O
flies	O
using	O
P	B
-	I
element	I
mediated	O
transformation	O
,	O
permitting	O
the	O
effects	O
of	O
the	O
mutant	O
genes	O
to	O
be	O
studied	O
in	O
vivo	O
in	O
the	O
indirect	O
flight	O
muscles	O
(	O
IFMs	O
)	O
.	O

Details	O
of	O
how	O
mechanical	O
experiments	O
can	O
be	O
performed	O
on	O
skinned	O
IFMs	O
,	O
despite	O
their	O
small	O
size	O
,	O
are	O
provided	O
.	O

The	O
effects	O
of	O
two	O
in	O
vitro	O
actin	B
mutations	O
,	O
G368E	O
and	O
E316	O
K	O
,	O
are	O
described	O
.	O

The	O
problems	O
of	O
performing	O
biochemical	O
and	O
biophysical	O
experiments	O
on	O
the	O
IFMs	O
and	O
their	O
myofibrillar	O
proteins	O
are	O
described	O
,	O
together	O
with	O
indications	O
as	O
to	O
how	O
these	O
may	O
be	O
overcome	O
.	O

The	O
genetic	O
structure	O
of	O
a	O
segregation	B
distorter	I
chromosome	O
(	O
a	O
derivative	O
of	O
SD-36	B
)	O
has	O
been	O
analyzed	O
in	O
a	O
system	O
in	O
which	O
recombination	O
in	O
the	O
second	O
chromosome	O
is	O
blocked	O
by	O
inversions	O
except	O
for	O
the	O
critical	O
region	O
around	O
the	O
centromeric	O
heterochromatin	O
.	O

The	O
results	O
confirm	O
the	O
map	O
order	O
and	O
characteristics	O
of	O
four	O
loci	O
known	O
to	O
be	O
involved	O
in	O
segregation	O
distortion	O
,	O
namely	O
Sd	B
,	O
E	B
(	I
SD	I
)	I
,	O
Rspins	O
,	O
M	B
(	I
SD	I
)	I
.	O

However	O
,	O
SD-36	B
carries	O
a	O
fifth	O
major	O
locus	O
involved	O
in	O
distortion	O
.	O

This	O
locus	O
is	O
near	O
pr	O
in	O
2L	O
and	O
has	O
the	O
effect	O
of	O
enhancing	O
the	O
degree	O
of	O
distortion	O
.	O

In	O
addition	O
,	O
reciprocal	O
recombinant	O
products	O
from	O
SD-36	B
are	O
recovered	O
unequally	O
.	O

All	O
recombinants	O
carrying	O
the	O
pr	O
region	O
from	O
SD-36	B
seem	O
also	O
to	O
carry	O
Sd	B
,	O
although	O
Sd	B
has	O
previously	O
been	O
mapped	O
1.6	O
units	O
to	O
the	O
left	O
of	O
pr	O
.	O

Both	O
the	O
enhancement	O
of	O
distortion	O
and	O
the	O
unequal	O
recovery	O
of	O
reciprocal	O
products	O
can	O
be	O
explained	O
if	O
it	O
is	O
assumed	O
that	O
the	O
new	O
locus	O
near	O
pr	O
in	O
SD-36	B
is	O
actually	O
a	O
duplication	O
of	O
Sd	B
.	O

Cellularization	O
of	O
the	O
Drosophila	O
embryo	O
requires	O
the	O
establishment	O
of	O
a	O
hexagonal	O
network	O
of	O
actin	O
and	O
myosin	O
filaments	O
that	O
are	O
interconnected	O
around	O
the	O
nuclei	O
in	O
the	O
cortex	O
of	O
the	O
syncytial	O
blastoderm	O
.	O

This	O
cytoskeletal	O
network	O
provides	O
the	O
framework	O
and	O
possibly	O
the	O
contractile	O
force	O
for	O
the	O
membrane	O
invaginations	O
that	O
synchronously	O
subdivide	O
the	O
syncytial	O
embryo	O
into	O
individual	O
cells	O
.	O

Zygotic	O
expression	O
of	O
the	O
nullo	B
locus	O
is	O
essential	O
for	O
the	O
preservation	O
of	O
an	O
intact	O
actin	O
-	O
myosin	O
network	O
.	O

Embryos	O
deleted	O
for	O
the	O
nullo	B
locus	O
have	O
a	O
disrupted	O
network	O
,	O
resulting	O
in	O
the	O
formation	O
of	O
many	O
multinucleate	O
cells	O
.	O

We	O
show	O
that	O
nullo	B
is	O
not	O
required	O
for	O
the	O
initial	O
formation	O
of	O
the	O
actin	O
-	O
myosin	O
network	O
,	O
but	O
is	O
necessary	O
for	O
the	O
maintenance	O
of	O
its	O
hexagonal	O
shape	O
during	O
cellularization	O
.	O

The	O
phenotype	O
of	O
embryonic	O
mosaics	O
is	O
nonautonomous	O
,	O
indicating	O
that	O
nullo	B
does	O
not	O
have	O
to	O
be	O
expressed	O
in	O
every	O
nucleus	O
for	O
proper	O
cellularization	O
.	O

Examination	O
of	O
nullo	B
mutant	O
clones	O
in	O
adults	O
reveals	O
that	O
nullo	B
activity	O
is	O
not	O
required	O
for	O
cell	O
division	O
in	O
imaginal	O
discs	O
.	O

Furthermore	O
,	O
germline	O
clone	O
experiments	O
suggest	O
that	O
maternal	O
expression	O
of	O
the	O
nullo	B
locus	O
is	O
not	O
essential	O
for	O
either	O
germline	O
proliferation	O
or	O
the	O
cellularization	O
of	O
progeny	O
.	O

We	O
propose	O
a	O
model	O
in	O
which	O
nullo	B
functions	O
specifically	O
at	O
cellularization	O
to	O
stabilize	O
the	O
actin	O
-	O
myosin	O
network	O
during	O
contraction	O
.	O

The	O
nucleotide	O
sequence	O
of	O
a	O
segment	O
of	O
the	O
mtDNA	B
molecule	O
of	O
Drosophila	O
yakuba	O
has	O
been	O
determined	O
,	O
within	O
which	O
have	O
been	O
identified	O
the	O
3	O
'	O
end	O
of	O
the	O
large	O
rRNA	O
gene	O
and	O
the	O
entire	O
genes	O
for	O
tRNAleuCUN	O
,	O
URF1	O
,	O
tRNAserUCN	O
,	O
cytochrome	O
b	O
,	O
URF6	O
,	O
tRNApro	O
,	O
tRNAthr	O
,	O
URF4L	O
,	O
URF4	O
,	O
tRNAhis	O
and	O
URF5	O
.	O

The	O
genes	O
are	O
arranged	O
in	O
the	O
order	O
given	O
,	O
with	O
the	O
large	O
rRNA	O
gene	O
being	O
closest	O
to	O
the	O
A+T	O
-	O
rich	O
region	O
which	O
contains	O
the	O
origin	O
of	O
replication	O
.	O

Transcription	O
of	O
all	O
of	O
these	O
genes	O
except	O
those	O
for	O
cytochrome	O
b	O
,	O
URF6	O
,	O
tRNAserUCN	O
and	O
tRNAthr	O
proceeds	O
in	O
the	O
same	O
direction	O
as	O
replication	O
.	O

Differences	O
occur	O
in	O
the	O
relative	O
arrangement	O
and	O
in	O
the	O
direction	O
of	O
transcription	O
of	O
these	O
twelve	O
genes	O
between	O
D.	O
yakuba	O
and	O
mammalian	O
mtDNA	B
molecules	O
.	O

Internal	O
AGA	O
codons	O
occur	O
in	O
all	O
of	O
the	O
polypeptide	O
genes	O
except	O
URF6	O
.	O

Comparisons	O
of	O
the	O
positions	O
of	O
these	O
AGA	O
codons	O
to	O
codons	O
in	O
corresponding	O
mouse	O
genes	O
is	O
consistent	O
with	O
the	O
view	O
that	O
in	O
the	O
D.	O
yakuba	O
mitochondrial	O
genetic	O
code	O
AGA	O
specifies	O
serine	O
.	O

Genes	O
equivalent	O
to	O
all	O
of	O
the	O
polypeptide	O
,	O
tRNA	O
and	O
rRNA	O
genes	O
found	O
in	O
mammalian	O
mtDNA	B
have	O
now	O
been	O
identified	O
in	O
D.	O
yakuba	O
mtDNA	B
.	O

Arthropods	B
exhibit	O
great	O
diversity	O
in	O
the	O
position	O
,	O
number	O
,	O
morphology	O
,	O
and	O
function	O
of	O
their	O
limbs	O
.	O

The	O
evolutionary	O
relations	O
among	O
limb	O
types	O
and	O
among	O
the	O
arthropod	O
groups	O
that	O
bear	O
them	O
(	O
insects	O
,	O
crustaceans	O
,	O
myriapods	O
,	O
and	O
chelicerates	O
)	O
are	O
controversial	O
.	O

Here	O
,	O
the	O
use	O
of	O
molecular	O
probes	O
,	O
including	O
an	O
antibody	O
to	O
proteins	O
encoded	O
by	O
arthropod	O
and	O
vertebrate	O
Distal	B
-	I
less	I
(	O
Dll	B
and	O
Dlx	O
)	O
genes	O
,	O
provided	O
evidence	O
that	O
common	O
genetic	O
mechanisms	O
underlie	O
the	O
development	O
of	O
all	O
arthropod	O
limbs	O
and	O
their	O
branches	O
and	O
that	O
all	O
arthropods	O
derive	O
from	O
a	O
common	O
ancestor	O
.	O

However	O
,	O
differences	O
between	O
crustacean	O
and	O
insect	O
body	O
plans	O
were	O
found	O
to	O
correlate	O
with	O
differences	O
in	O
the	O
deployment	O
of	O
particular	O
homeotic	O
genes	O
and	O
in	O
the	O
ways	O
that	O
these	O
genes	O
regulate	O
limb	O
development	O
.	O

Dorsal	B
-	O
ventral	O
patterning	O
within	O
the	O
ectoderm	O
of	O
the	O
Drosophila	O
embryo	O
requires	O
seven	O
zygotic	O
genes	O
,	O
including	O
short	B
gastrulation	I
(	O
sog	B
)	O
.	O

Here	O
we	O
demonstrate	O
that	O
sog	B
,	O
which	O
is	O
expressed	O
in	O
the	O
ventrolateral	O
region	O
of	O
the	O
embryo	O
that	O
gives	O
rise	O
to	O
the	O
nerve	O
cord	O
,	O
is	O
functionally	O
homologous	O
to	O
the	O
chordin	B
gene	O
of	O
Xenopus	O
,	O
which	O
is	O
expressed	O
in	O
the	O
dorsal	B
blastopore	O
lip	O
of	O
the	O
embryo	O
and	O
in	O
dorsal	B
mesoderm	O
,	O
in	O
particular	O
the	O
notochord	O
.	O

We	O
show	O
by	O
injections	O
of	O
messenger	O
RNA	O
that	O
both	O
sog	B
and	O
chordin	B
can	O
promote	O
ventral	O
development	O
in	O
Drosophila	O
,	O
and	O
that	O
sog	B
,	O
like	O
chordin	B
,	O
can	O
promote	O
dorsal	B
development	O
in	O
Xenopus	O
.	O

In	O
Drosophila	O
,	O
sog	B
antagonizes	O
the	O
dorsalizing	O
effects	O
of	O
decapentaplegic	B
(	O
dpp	B
)	O
,	O
a	O
member	O
of	O
the	O
transforming	O
growth	O
factor	O
-	O
beta	O
family	O
.	O

One	O
of	O
the	O
dpp	B
homologues	O
in	O
vertebrates	O
,	O
bmp-4	O
,	O
is	O
expressed	O
ventrally	O
in	O
Xenopus	O
and	O
promotes	O
ventral	O
development	O
.	O

We	O
show	O
that	O
dpp	B
can	O
promote	O
ventral	O
fates	O
in	O
Xenopus	O
,	O
and	O
that	O
injection	O
of	O
sog	B
mRNA	O
counteracts	O
the	O
ventralizing	O
effects	O
of	O
dpp	B
.	O

These	O
results	O
suggest	O
the	O
molecular	O
conservation	O
of	O
dorsoventral	O
patterning	O
mechanisms	O
during	O
evolution	O
.	O

The	O
three	O
yolk	O
proteins	O
(	O
YP1	B
,	O
YP2	B
and	O
YP3	B
)	O
of	O
Drosophila	O
melanogaster	O
are	O
synthesized	O
in	O
two	O
tissues	O
of	O
the	O
adult	O
female	O
,	O
the	O
fat	O
body	O
and	O
ovarian	O
follicle	O
cells	O
.	O

The	O
YPs	O
are	O
selectively	O
accumulated	O
in	O
the	O
oocyte	O
to	O
provide	O
nutrients	O
for	O
embryogenesis	O
.	O

We	O
describe	O
a	O
female	O
-	O
sterile	O
mutant	O
,	O
fs	O
(	O
1	O
)	O
A1526	O
,	O
which	O
lacks	O
YP3	B
in	O
the	O
haemolymph	O
.	O

The	O
female	O
sterility	O
mutation	O
mapped	O
some	O
distance	O
away	O
from	O
the	O
yp3	B
gene	O
on	O
the	O
X	B
chromosome	O
and	O
we	O
were	O
able	O
to	O
separate	O
the	O
YP3	B
defect	O
from	O
the	O
female	O
sterility	O
by	O
recombination	O
,	O
thus	O
producing	O
a	O
fertile	O
line	O
of	O
flies	O
having	O
no	O
YP3	B
in	O
the	O
eggs	O
.	O

This	O
shows	O
that	O
YP3	B
is	O
not	O
essential	O
for	O
embryogenesis	O
.	O

The	O
mutant	O
line	O
is	O
to	O
be	O
known	O
as	O
YP3s1	O
.	O

Investigation	O
of	O
yp3	B
transcription	O
in	O
the	O
mutant	O
females	O
revealed	O
that	O
the	O
gene	O
is	O
transcribed	O
but	O
yp3s1	O
mRNA	O
levels	O
are	O
reduced	O
relative	O
to	O
wild	O
type	O
.	O

Transcription	O
of	O
the	O
mutant	O
yp3	B
gene	O
can	O
be	O
induced	O
in	O
males	O
by	O
ecdysone	O
.	O

Investigation	O
of	O
the	O
yolk	O
proteins	O
in	O
YP3s1	O
females	O
suggested	O
that	O
the	O
YP3s1	O
polypeptide	O
is	O
synthesized	O
in	O
the	O
fat	O
body	O
but	O
not	O
secreted	O
.	O

The	O
mutant	O
YP3	B
protein	O
shows	O
an	O
increase	O
in	O
apparent	O
molecular	O
weight	O
of	O
approximately	O
1	O
kDa	O
.	O

The	O
mutant	O
yp3	B
gene	O
was	O
cloned	O
and	O
the	O
DNA	O
sequence	O
determined	O
.	O

The	O
sequence	O
differences	O
between	O
the	O
mutant	O
and	O
wild	O
-	O
type	O
genes	O
include	O
an	O
amino	O
acid	O
substitution	O
in	O
the	O
leader	O
sequence	O
.	O

We	O
suggest	O
that	O
this	O
may	O
be	O
responsible	O
for	O
the	O
failure	O
of	O
YP3	B
secretion	O
in	O
the	O
mutant	O
YP3s1	O
,	O
and	O
speculate	O
on	O
the	O
cause	O
of	O
the	O
reduction	O
seen	O
in	O
the	O
steady	O
-	O
state	O
level	O
of	O
yp3	B
mRNA	O
.	O

We	O
have	O
examined	O
the	O
RNA	O
expression	O
pattern	O
for	O
the	O
Drosophila	O
calmodulin	B
gene	O
during	O
embryogenesis	O
by	O
in	O
situ	O
hybridization	O
to	O
transcripts	O
in	O
whole	O
embryos	O
.	O

Our	O
results	O
indicate	O
that	O
maternally	O
derived	O
calmodulin	B
mRNA	O
is	O
homogeneously	O
distributed	O
throughout	O
the	O
early	O
embryo	O
,	O
but	O
that	O
these	O
maternal	O
transcripts	O
are	O
lost	O
by	O
maximal	O
germ	O
band	O
extension	O
.	O

Zygotic	O
transcription	O
of	O
the	O
gene	O
in	O
mid-	O
to	O
late	O
-	O
stage	O
embryos	O
is	O
restricted	O
to	O
neural	O
cell	O
precursors	O
and	O
their	O
progeny	O
in	O
both	O
the	O
central	O
and	O
peripheral	O
nervous	O
systems	O
.	O

Thus	O
,	O
activation	O
of	O
calmodulin	B
transcription	O
during	O
embryonic	O
development	O
appears	O
to	O
mark	O
a	O
commitment	O
to	O
a	O
neural	O
fate	O
.	O

Northern	O
blot	O
analysis	O
revealed	O
that	O
the	O
two	O
transcripts	O
from	O
the	O
calmodulin	B
gene	O
are	O
differentially	O
expressed	O
during	O
embryogenesis	O
.	O

Comparison	O
of	O
Northern	O
blot	O
and	O
in	O
situ	O
hybridization	O
data	O
indicates	O
that	O
the	O
longer	O
calmodulin	B
mRNA	O
is	O
a	O
nervous	O
tissue	O
-	O
specific	O
transcript	O
.	O

This	O
suggests	O
that	O
neural	O
-	O
specific	O
regulation	O
of	O
polyadenylation	O
site	O
usage	O
occurs	O
.	O

We	O
have	O
also	O
examined	O
calmodulin	B
expression	O
in	O
embryos	O
homozygous	O
for	O
mutations	O
in	O
four	O
loci	O
which	O
are	O
known	O
to	O
affect	O
nervous	O
system	O
development	O
:	O
numb	B
,	O
the	O
achaete	B
-	I
scute	I
complex	I
,	O
daughterless	B
,	O
and	O
mastermind	B
.	O

The	O
calmodulin	B
transcription	O
pattern	O
is	O
altered	O
in	O
embryos	O
mutant	O
for	O
each	O
of	O
these	O
loci	O
,	O
suggesting	O
that	O
regulation	O
by	O
these	O
genes	O
,	O
either	O
directly	O
or	O
indirectly	O
,	O
is	O
taking	O
place	O
.	O

A	B
goal	O
of	O
modern	O
biology	O
is	O
to	O
identify	O
the	O
physical	O
interactions	O
that	O
define	O
'	O
functional	O
modules	O
'	O
of	O
proteins	O
that	O
govern	O
biological	O
processes	O
.	O

One	O
essential	O
regulatory	O
process	O
is	O
the	O
maintenance	O
of	O
master	O
regulatory	O
genes	O
,	O
such	O
as	O
homeotic	O
genes	O
,	O
in	O
an	O
appropriate	O
'	O
on	O
'	O
or	O
'	O
off	O
'	O
state	O
for	O
the	O
lifetime	O
of	O
an	O
organism	O
.	O

The	O
Polycomb	B
group	O
(	O
PcG	O
)	O
of	O
genes	O
maintain	O
a	B
repressed	O
transcriptional	O
state	O
,	O
and	O
PcG	O
proteins	O
form	O
large	O
multiprotein	O
complexes	O
,	O
but	O
these	O
complexes	O
have	O
not	O
been	O
described	O
owing	O
to	O
inherent	O
difficulties	O
in	O
purification	O
.	O

We	O
previously	O
fractionated	O
a	B
major	O
PcG	O
complex	O
,	O
PRC1	O
,	O
to	O
20	O
-	O
50	O
%	O
homogeneity	O
from	O
Drosophila	O
embryos	O
.	O

Here	O
,	O
we	O
identify	O
30	O
proteins	O
in	O
these	O
preparations	O
,	O
then	O
further	O
fractionate	O
the	O
preparation	O
and	O
use	O
western	O
analyses	O
to	O
validate	O
unanticipated	O
connections	O
.	O

We	O
show	O
that	O
the	O
known	O
PcG	O
proteins	O
Polycomb	B
,	O
Posterior	B
sex	I
combs	I
,	O
Polyhomeotic	B
and	O
dRING1	B
exist	O
in	O
robust	O
association	O
with	O
the	O
sequence	O
-	O
specific	O
DNA	O
-	O
binding	O
factor	O
Zeste	B
and	O
with	O
numerous	O
TBP	B
(	O
TATA	O
-	O
binding	O
-	O
protein	O
)	O
-associated	O
factors	O
that	O
are	O
components	O
of	O
general	O
transcription	O
factor	O
TFIID	B
(	O
dTAFIIs	O
)	O
.	O

Thus	O
,	O
in	O
fly	O
embryos	O
,	O
there	O
is	O
a	B
direct	O
physical	O
connection	O
between	O
proteins	O
that	O
bind	O
to	O
specific	O
regulatory	O
sequences	O
,	O
PcG	O
proteins	O
,	O
and	O
proteins	O
of	O
the	O
general	O
transcription	O
machinery	O
.	O

We	O
have	O
developed	O
an	O
in	O
vitro	O
reaction	O
system	O
for	O
Drosophila	O
P	B
element	I
transposition	O
.	O

Transposition	O
products	O
were	O
recovered	O
by	O
selection	O
in	O
E.	O
coli	O
,	O
and	O
contained	O
simple	O
P	B
element	I
insertions	O
flanked	O
by	O
8	O
bp	O
target	O
site	O
duplications	O
as	O
observed	O
in	O
vivo	O
.	O

Transposition	O
required	O
Mg+2	O
and	O
partially	O
purified	O
P	B
element	I
transposase	I
.	O

Unlike	O
other	O
DNA	O
rearrangement	O
reactions	O
,	O
P	B
element	I
transposition	O
in	O
vitro	O
used	O
GTP	O
as	O
a	O
cofactor	O
;	O
deoxyGTP	O
,	O
dideoxyGTP	O
,	O
or	O
the	O
nonhydrolyzable	O
GTP	O
analogs	O
GMP	O
-	O
PNP	O
or	O
GMP	O
-	O
PCP	O
were	O
also	O
used	O
.	O

Transposon	O
DNA	O
molecules	O
cleaved	O
at	O
the	O
P	B
element	I
termini	O
were	O
able	O
to	O
transpose	O
,	O
but	O
those	O
lacking	O
3'-hydroxyl	O
groups	O
were	O
inactive	O
.	O

These	O
biochemical	O
data	O
are	O
consistent	O
with	O
genetic	O
data	O
suggesting	O
that	O
P	B
element	I
transposition	O
occurs	O
via	O
a	O
""""	O
cut	O
-	O
and	O
-	O
paste	O
""""	O
mechanism	O
.	O

The	O
extracellular	O
signal	O
-	O
regulated	O
kinases	O
(	O
ERKs	O
)	O
comprise	O
a	O
class	O
of	O
protein	O
-	O
serine	O
/	O
threonine	O
kinases	O
that	O
are	O
activated	O
in	O
response	O
to	O
a	O
wide	O
variety	O
of	O
extracellular	O
signals	O
transduced	O
via	O
receptor	O
tyrosine	O
kinases	O
.	O

Activation	O
of	O
the	O
ERKs	O
requires	O
both	O
threonine	O
and	O
tyrosine	O
phosphorylation	O
suggestive	O
of	O
a	O
key	O
role	O
in	O
mediating	O
intracellular	O
events	O
in	O
response	O
to	O
extracellular	O
cues	O
.	O

To	O
critically	O
assess	O
the	O
role	O
of	O
ERKs	O
in	O
intracellular	O
signaling	O
,	O
a	O
genetically	O
tractable	O
receptor	O
tyrosine	O
kinase	O
system	O
would	O
be	O
invaluable	O
.	O

In	O
this	O
paper	O
we	O
report	O
the	O
identification	O
of	O
a	O
Drosophila	O
homolog	O
of	O
ERK1	B
and	O
-2	O
,	O
designated	O
DmERK	B
-	I
A.	I
DmERK	B
-	I
A	I
is	O
80	O
%	O
identical	O
to	O
rat	O
ERK1	B
and	O
-2	O
and	O
is	O
rapidly	O
phosphorylated	O
on	O
tyrosine	O
in	O
response	O
to	O
an	O
extracellular	O
signal	O
activating	O
a	O
receptor	O
tyrosine	O
kinase	O
.	O

Biochemical	O
and	O
histological	O
studies	O
reveal	O
its	O
expression	O
in	O
the	O
eye	O
imaginal	O
disc	O
.	O

These	O
studies	O
provide	O
a	O
first	O
step	O
in	O
a	O
genetic	O
analysis	O
of	O
ERK	B
function	O
.	O

We	O
have	O
expressed	O
two	O
antifreeze	O
protein	O
genes	O
from	O
the	O
Atlantic	O
wolffish	O
,	O
Anarhichas	O
lupus	O
,	O
in	O
Drosophila	O
melanogaster	O
by	O
placing	O
them	O
under	O
the	O
divergent	O
transcriptional	O
control	O
of	O
the	O
host	O
yolk	O
polypeptide	O
(	O
1	O
and	O
2	O
)	O
gene	O
promoters	O
.	O

Both	O
genes	O
were	O
joined	O
to	O
the	O
central	O
promoter	O
region	O
by	O
fusion	O
within	O
the	O
DNA	O
encoding	O
the	O
signal	O
polypeptides	O
.	O

The	O
chimeric	O
genes	O
were	O
introduced	O
into	O
flightless	O
mutant	O
Drosophila	O
through	O
P	B
-	I
element	I
transformation	O
.	O

Transformed	O
adult	O
females	O
from	O
individual	O
lines	O
accumulated	O
1.5	O
-	O
5	O
mg	O
/	O
ml	O
of	O
antifreeze	O
protein	O
in	O
their	O
hemolymph	O
.	O

The	O
protein	O
was	O
purified	O
to	O
homogeneity	O
from	O
hemolymph	O
following	O
thermal	O
denaturation	O
,	O
step	O
elution	O
from	O
SP	O
-	O
Sephadex	O
,	O
and	O
reverse	O
-	O
phase	O
HPLC	O
.	O

It	O
was	O
recovered	O
in	O
high	O
yield	O
and	O
retained	O
full	O
biological	O
activity	O
even	O
though	O
one	O
of	O
the	O
two	O
gene	O
fusions	O
gave	O
rise	O
to	O
a	O
seven	O
amino	O
acid	O
N	O
-	O
terminal	O
extension	O
on	O
its	O
antifreeze	O
protein	O
product	O
.	O

cDNA	O
clones	O
encoding	O
the	O
BALB	O
/	O
c	O
murine	O
erythrocyte	O
band	O
7	O
integral	O
membrane	O
protein	O
(	O
also	O
termed	O
protein	B
7.2b	I
,	O
or	O
'	O
stomatin	B
'	O
)	O
were	O
isolated	O
by	O
the	O
screening	O
of	O
a	O
corresponding	O
bone	O
-	O
marrow	O
lambda	O
gt11	O
cDNA	O
library	O
with	O
a	O
human	O
cDNA	O
probe	O
,	O
and	O
by	O
5'-RACE	O
PCR	O
cloning	O
.	O

Comparison	O
of	O
the	O
murine	O
,	O
human	O
and	O
Caenorhabditis	O
elegans	O
protein	B
7.2b	I
amino	O
acid	O
(	O
aa	O
)	O
sequences	O
revealed	O
overall	O
identities	O
of	O
88	O
%	O
(	O
human	O
)	O
and	O
61	O
%	O
(	O
C.	O
elegans	O
)	O
,	O
with	O
the	O
N	O
-	O
terminal	O
domains	O
showing	O
only	O
little	O
similarity	O
.	O

The	O
7.2b	O
protein	O
sequences	O
of	O
the	O
two	O
mouse	O
strains	O
,	O
BALB	O
/	O
c	O
and	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
,	O
showed	O
six	O
rather	O
conservative	O
aa	O
substitutions	O
,	O
three	O
of	O
them	O
in	O
the	O
hydrophobic	O
domain	O
.	O

The	O
BALB	O
/	O
c	O
murine	O
mRNA	O
,	O
about	O
3.5	O
kb	O
in	O
size	O
,	O
is	O
widely	O
expressed	O
in	O
various	O
tissues	O
,	O
most	O
notably	O
in	O
spleen	O
,	O
lung	O
and	O
testis	O
.	O

Using	O
a	O
transgenic	O
mouse	O
derived	O
GnRH	B
expressing	O
neuronal	O
cell	O
line	O
,	O
GT1	O
-	O
3	O
,	O
we	O
studied	O
the	O
effects	O
of	O
activation	O
of	O
cAMP	O
,	O
Ca2	O
+	O
and	O
protein	O
kinase	O
C	O
pathways	O
by	O
forskolin	O
,	O
ionomycin	O
and	O
the	O
phorbol	O
ester	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
,	O
respectively	O
,	O
upon	O
gonadotropin	O
-	O
releasing	O
hormone	O
(	O
GnRH	B
)	O
secretion	O
,	O
cellular	O
peptide	O
content	O
,	O
mRNA	O
and	O
RNA	O
primary	O
transcript	O
levels	O
.	O

Forskolin	O
,	O
ionomycin	O
and	O
phorbol	O
ester	O
all	O
caused	O
an	O
increase	O
in	O
GnRH	B
secretion	O
in	O
GT1	O
-	O
3	O
cells	O
in	O
a	O
time	O
and	O
dose	O
-	O
dependent	O
manner	O
during	O
a	O
short	O
-	O
term	O
(	O
1	O
h	O
)	O
static	O
incubation	O
.	O

Prolonged	O
treatment	O
with	O
forskolin	O
(	O
10	O
microM	O
)	O
,	O
ionomycin	O
(	O
1	O
microM	O
)	O
and	O
PMA	O
(	O
10	O
nM	O
)	O
for	O
12	O
or	O
24	O
h	O
resulted	O
in	O
significant	O
decreases	O
in	O
GnRH	B
mRNA	O
levels	O
.	O

Time	O
-	O
course	O
studies	O
showed	O
that	O
the	O
increases	O
in	O
GnRH	B
secretion	O
stimulated	O
by	O
forskolin	O
,	O
ionomycin	O
and	O
PMA	O
were	O
gradually	O
attenuated	O
over	O
time	O
in	O
parallel	O
with	O
the	O
decreases	O
in	O
mRNA	O
expression	O
.	O

In	O
contrast	O
,	O
there	O
were	O
only	O
small	O
and	O
variable	O
changes	O
in	O
the	O
GnRH	B
cellular	O
content	O
.	O

Studies	O
using	O
a	O
GnRH	B
antagonist	O
(	O
100	O
microM	O
)	O
suggested	O
that	O
the	O
released	O
GnRH	B
has	O
a	O
negative	O
feedback	O
effect	O
on	O
its	O
own	O
secretion	O
.	O

However	O
,	O
co	O
-	O
incubation	O
with	O
the	O
GnRH	B
antagonist	O
did	O
not	O
alter	O
the	O
inhibitory	O
effects	O
on	O
GnRH	B
mRNA	O
levels	O
by	O
the	O
secretagogues	O
.	O

Further	O
studies	O
on	O
the	O
transcriptional	O
effects	O
of	O
forskolin	O
,	O
ionomycin	O
and	O
PMA	O
on	O
GnRH	B
gene	O
expression	O
in	O
GT1	O
-	O
3	O
cells	O
revealed	O
that	O
all	O
three	O
secretagogues	O
suppressed	O
GnRH	B
RNA	O
primary	O
transcript	O
levels	O
,	O
with	O
forskolin	O
having	O
a	O
slower	O
time	O
course	O
of	O
action	O
.	O

Thus	O
,	O
the	O
inhibition	O
of	O
cytoplasmic	O
GnRH	B
mRNA	O
,	O
and	O
presumably	O
its	O
synthesis	O
,	O
after	O
12	O
-	O
24	O
h	O
of	O
secretagogue	O
treatment	O
may	O
be	O
due	O
at	O
least	O
in	O
part	O
to	O
a	O
suppression	O
of	O
GnRH	B
gene	O
transcription.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	O
primary	O
structures	O
of	O
interferon	O
(	O
IFN	O
)	O
-induced	O
guanylate	O
-	O
binding	O
proteins	O
(	O
GBPs	O
)	O
were	O
deduced	O
from	O
cloned	O
human	O
and	O
murine	O
cDNAs	O
.	O

These	O
proteins	O
contained	O
only	O
two	O
of	O
the	O
three	O
sequence	O
motifs	O
typically	O
found	O
in	O
GTP	O
/	O
GDP	O
-	O
binding	O
proteins	O
.	O

The	O
N	O
(	O
T	O
)	O
KXD	O
motif	O
,	O
which	O
is	O
believed	O
to	O
confer	O
guanine	O
specificity	O
in	O
other	O
nucleotide	O
-	O
binding	O
proteins	O
,	O
was	O
absent	O
.	O

Nevertheless	O
,	O
the	O
IFN	O
-	O
induced	O
GBPs	O
exhibited	O
a	O
high	O
degree	O
of	O
selectivity	O
for	O
binding	O
to	O
agarose	O
-	O
immobilized	O
guanine	O
nucleotides	O
.	O

An	O
interesting	O
feature	O
of	O
IFN	O
-	O
induced	O
GBPs	O
is	O
that	O
they	O
strongly	O
bound	O
to	O
GMP	O
agarose	O
in	O
addition	O
to	O
GDP	O
and	O
GTP	O
agaroses	O
but	O
failed	O
to	O
bind	O
to	O
ATP	O
agarose	O
and	O
all	O
other	O
nucleotide	O
agaroses	O
tested	O
.	O

Both	O
GTP	O
and	O
GMP	O
,	O
but	O
not	O
ATP	O
,	O
competed	O
for	O
binding	O
of	O
murine	O
GBP-1	B
to	O
agarose	O
-	O
immobilized	O
GMP	O
.	O

The	O
IFN	O
-	O
induced	O
GBPs	O
thus	O
define	O
a	O
distinct	O
novel	O
family	O
of	O
proteins	O
with	O
GTP	O
-	O
binding	O
activity	O
.	O

We	O
further	O
demonstrate	O
that	O
human	O
and	O
murine	O
cells	O
contain	O
at	O
least	O
two	O
genes	O
encoding	O
IFN	O
-	O
induced	O
GBPs	O
.	O

The	O
cloned	O
murine	O
cDNA	O
codes	O
for	O
GBP-1	B
,	O
an	O
IFN	O
-	O
induced	O
protein	O
previously	O
shown	O
to	O
be	O
absent	O
from	O
mice	O
of	O
Gbp-1b	O
genotype	O
.	O

Dominant	B
megacolon	I
(	O
Dom	B
)	O
is	O
one	O
of	O
four	O
mutations	O
in	O
the	O
mouse	O
that	O
can	O
produce	O
a	O
phenotype	O
similar	O
to	O
Hirschsprung	O
disease	O
in	O
human	O
.	O

The	O
Dom	B
gene	O
product	O
is	O
not	O
known	O
,	O
and	O
no	O
candidate	O
region	O
has	O
been	O
defined	O
for	O
a	O
possible	O
human	O
homolog	O
.	O

In	O
this	O
publication	O
we	O
report	O
mapping	O
the	O
Dom	B
locus	O
with	O
high	O
definition	O
,	O
using	O
several	O
intra	O
-	O
and	O
interspecific	O
crosses	O
and	O
a	O
set	O
of	O
16	O
Chr	O
15-specific	O
microsatellites	O
flanking	O
this	O
locus	O
.	O

Zp1	B
encodes	O
one	O
of	O
the	O
three	O
major	O
glycoproteins	O
of	O
the	O
zona	O
pellucida	O
,	O
an	O
extracellular	O
matrix	O
that	O
surrounds	O
growing	O
oocytes	O
,	O
ovulated	O
eggs	O
,	O
and	O
preimplantation	O
embryos	O
.	O

The	O
mouse	O
gene	O
is	O
composed	O
of	O
12	O
exons	O
ranging	O
in	O
size	O
from	O
82	O
to	O
364	O
base	O
pairs	O
and	O
spans	O
6.5	O
kilobase	O
pairs	O
on	O
chromosome	O
19	O
(	O
2.13	O
+	O
/-	O

1.5	O
centimorgans	O
distal	O
to	O
D19Bir1	B
)	O
.	O

The	O
Zp1	B
exon	O
map	O
is	O
similar	O
to	O
ZPB	O
,	O
a	O
human	O
orthologue	O
,	O
and	O
an	O
E	O
-	O
box	O
(	O
CANNTG	O
)	O
,	O
implicated	O
in	O
oocyte	O
-	O
specific	O
gene	O
expression	O
of	O
mouse	O
Zp2	O
and	O
Zp3	O
,	O
is	O
similarly	O
located	O
upstream	O
of	O
the	O
transcription	O
start	O
site	O
.	O

The	O
single	O
copy	O
Zp1	B
gene	O
encodes	O
a	O
623-amino	O
acid	O
protein	O
,	O
the	O
carboxyl	O
-	O
terminal	O
half	O
of	O
which	O
is	O
significantly	O
similar	O
to	O
a	O
corresponding	O
region	O
of	O
mouse	O
ZP2	O
.	O

The	O
conservation	O
of	O
this	O
same	O
region	O
in	O
a	O
fish	O
egg	O
envelope	O
protein	O
suggests	O
that	O
not	O
only	O
has	O
this	O
protein	O
domain	O
been	O
duplicated	O
in	O
mammals	O
but	O
that	O
it	O
has	O
been	O
conserved	O
and	O
used	O
as	O
an	O
egg	O
envelope	O
protein	O
in	O
species	O
that	O
diverged	O
650	O
million	O
years	O
ago	O
.	O

Glycogen	O
storage	O
disease	O
type	O
1a	O
(	O
GSD-1a	O
)	O
,	O
characterized	O
by	O
hypoglycemia	O
,	O
liver	O
and	O
kidney	O
enlargement	O
,	O
growth	O
retardation	O
,	O
hyperlipidemia	O
,	O
and	O
hyperuricemia	O
,	O
is	O
caused	O
by	O
a	O
deficiency	O
in	O
glucose-6-phosphatase	O
(	O
G6Pase	B
)	O
,	O
a	O
key	O
enzyme	O
in	O
glucose	O
homeostasis	O
.	O

To	O
evaluate	O
the	O
feasibility	O
of	O
gene	O
replacement	O
therapy	O
for	O
GSD-1a	O
,	O
we	O
have	O
infused	O
adenoviral	O
vector	O
containing	O
the	O
murine	O
G6Pase	B
gene	O
(	O
Ad	O
-	O
mG6Pase	O
)	O
into	O
G6Pase	B
-	O
deficient	O
(	O
G6Pase	B
(	I
-	I
/	I
-	I
)	I
)	O
mice	O
that	O
manifest	O
symptoms	O
characteristic	O
of	O
human	O
GSD-1a	O
.	O

Whereas	O
<	O
15	O
%	O
of	O
G6Pase	B
(	I
-	I
/	I
-	I
)	I
mice	O
under	O
glucose	O
therapy	O
survived	O
weaning	O
,	O
a	O
100	O
%	O
survival	O
rate	O
was	O
achieved	O
when	O
G6Pase	B
(	I
-	I
/	I
-	I
)	I
mice	O
were	O
infused	O
with	O
Ad	O
-	O
mG6Pase	O
,	O
90	O
%	O
of	O
which	O
lived	O
to	O
3	O
months	O
of	O
age	O
.	O

Hepatic	O
G6Pase	B
activity	O
in	O
Ad	O
-	O
mG6Pase	O
-	O
infused	O
mice	O
was	O
restored	O
to	O
19	O
%	O
of	O
that	O
in	O
G6Pase	B
(	I
+	I
/	I
+	I
)	I
mice	O
at	O
7	O
-	O
14	O
days	O
post	O
-	O
infusion	O
;	O
the	O
activity	O
persisted	O
for	O
at	O
least	O
70	O
days	O
.	O

Ad	O
-	O
mG6Pase	O
infusion	O
also	O
greatly	O
improved	O
growth	O
of	O
G6Pase	B
(	I
-	I
/	I
-	I
)	I
mice	O
and	O
normalized	O
plasma	O
glucose	O
,	O
cholesterol	O
,	O
triglyceride	O
,	O
and	O
uric	O
acid	O
profiles	O
.	O

Furthermore	O
,	O
liver	O
and	O
kidney	O
enlargement	O
was	O
less	O
pronounced	O
with	O
near	O
-	O
normal	O
levels	O
of	O
glycogen	O
depositions	O
in	O
both	O
organs	O
.	O

Our	O
data	O
demonstrate	O
that	O
a	O
single	O
administration	O
of	O
a	O
recombinant	O
adenoviral	O
vector	O
can	O
alleviate	O
the	O
pathological	O
manifestations	O
of	O
GSD-1a	O
in	O
mice	O
,	O
suggesting	O
that	O
this	O
disorder	O
in	O
humans	O
can	O
potentially	O
be	O
corrected	O
by	O
gene	O
therapy	O
.	O

The	O
role	O
of	O
metallothionein	O
with	O
regard	O
to	O
cadmium	O
toxicity	O
in	O
vitro	O
was	O
investigated	O
using	O
preimplantation	O
mouse	O
blastocysts	O
derived	O
from	O
a	O
transgenic	O
strain	O
that	O
constitutively	O
overexpresses	O
metallothionein	O
-	O
I	O
transgenes	O
(	O
MT	B
-	I
I	I
*	O
)	O
.	O

Northern	O
blot	O
and	O
in	O
situ	O
hybridization	O
revealed	O
high	O
levels	O
of	O
MT	B
-	I
I	I
mRNA	O
in	O
transgenic	O
blastocysts	O
when	O
compared	O
with	O
control	O
blastocysts	O
,	O
and	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
-	O
amplified	O
MT	B
-	I
I	I
mRNA	O
was	O
almost	O
exclusively	O
MT	B
-	I
I*.	I
Moreover	O
,	O
pulse	O
-	O
labeling	O
experiments	O
showed	O
that	O
the	O
relative	O
rate	O
of	O
synthesis	O
of	O
MT	O
was	O
9-fold	O
higher	O
in	O
transgenic	O
blastocysts	O
.	O

Cadmium	O
(	O
Cd2	O
+	O
)	O
toxicity	O
was	O
assessed	O
after	O
incubating	O
blastocysts	O
for	O
4	O
hr	O
in	O
Whitten	O
's	O
medium	O
containing	O
50	O
microM	O
Cd2	O
+	O
.	O

Embryos	O
that	O
displayed	O
abnormal	O
morphology	O
were	O
judged	O
""""	O
sensitive	O
""""	O
.	O

Transgenic	O
blastocysts	O
were	O
more	O
resistant	O
to	O
cadmium	O
-	O
induced	O
morphological	O
changes	O
than	O
were	O
control	O
blastocysts	O
.	O
""""	O

Sensitive	O
""""	O
and	O
""""	O
resistant	O
""""	O
blastocysts	O
were	O
individually	O
genotyped	O
by	O
polymerase	O
chain	O
reaction	O
,	O
or	O
they	O
were	O
transferred	O
to	O
foster	O
mothers	O
,	O
and	O
embryonic	O
development	O
to	O
midterm	O
was	O
monitored	O
.	O

Of	O
the	O
blastocysts	O
derived	O
from	O
mating	O
heterozygous	O
transgenic	O
males	O
with	O
control	O
females	O
,	O
56	O
%	O
were	O
transgenic	O
before	O
incubation	O
with	O
Cd2	O
+	O
,	O
whereas	O
95	O
%	O
of	O
the	O
blastocysts	O
that	O
retained	O
normal	O
morphology	O
after	O
incubation	O
were	O
transgenic	O
.	O

Moreover	O
,	O
after	O
Cd2	O
+	O
exposure	O
,	O
transgenic	O
blastocysts	O
with	O
normal	O
morphology	O
were	O
nine	O
times	O
more	O
likely	O
to	O
develop	O
to	O
midterm	O
than	O
were	O
control	O
blastocysts	O
with	O
normal	O
morphology	O
.	O

Blastocysts	O
with	O
abnormal	O
morphology	O
failed	O
to	O
develop	O
to	O
midterm	O
.	O

These	O
studies	O
indicate	O
that	O
MT	O
plays	O
a	O
central	O
role	O
in	O
protection	O
from	O
Cd2	O
+	O
toxicity	O
within	O
the	O
physiological	O
context	O
of	O
the	O
developing	O
mouse	O
embryo	O
.	O

Breast	O
cancer	O
is	O
the	O
most	O
frequent	O
tumor	O
type	O
among	O
women	O
in	O
the	O
United	O
States	O
and	O
in	O
individuals	O
with	O
Li	O
-	O
Fraumeni	O
syndrome	O
.	O

The	O
p53	B
tumor	O
suppressor	O
gene	O
is	O
altered	O
in	O
a	O
large	O
proportion	O
of	O
both	O
spontaneous	O
breast	O
malignancies	O
and	O
Li	O
-	O
Fraumeni	O
breast	O
cancers	O
.	O

This	O
suggests	O
that	O
loss	O
of	O
p53	B
can	O
accelerate	O
breast	O
tumorigenesis	O
,	O
yet	O
p53-deficient	B
mice	O
rarely	O
develop	O
mammary	O
tumors	O
.	O

To	O
evaluate	O
the	O
effect	O
of	O
p53	B
loss	O
on	O
mammary	O
tumor	O
formation	O
,	O
the	O
p53	B
(	I
null	I
)	I
allele	O
was	O
back	O
-	O
crossed	O
onto	O
the	O
BALB	O
/	O
c	O
genetic	O
background	O
.	O

Median	O
survival	O
was	O
15.4	O
weeks	O
for	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
-	I
/	I
-	I
)	I
mice	O
compared	O
to	O
54	O
weeks	O
for	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
+	I
/	I
-	I
)	I
mice	O
.	O

Sarcomas	O
and	O
lymphomas	O
were	O
the	O
most	O
frequent	O
tumor	O
types	O
in	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
-	I
/	I
-	I
)	I
mice	O
,	O
whereas	O
55	O
%	O
of	O
the	O
female	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
+	I
/	I
-	I
)	I
mice	O
developed	O
mammary	O
carcinomas	O
.	O

The	O
mammary	O
tumors	O
were	O
highly	O
aneuploid	O
,	O
frequently	O
lost	O
the	O
remaining	O
wild	O
-	O
type	O
p53	B
allele	O
,	O
but	O
rarely	O
lost	O
BRCA1	O
.	O

Although	O
mammary	O
tumors	O
were	O
rarely	O
detected	O
in	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
-	I
/	I
-	I
)	I
female	O
mice	O
,	O
when	O
glands	O
from	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
-	I
/	I
-	I
)	I
mice	O
were	O
transplanted	O
into	O
wild	O
-	O
type	O
BALB	O
/	O
c	O
hosts	O
,	O
75	O
%	O
developed	O
mammary	O
tumors	O
.	O

The	O
high	O
rate	O
of	O
mammary	O
tumor	O
development	O
in	O
the	O
BALB	O
/	O
c	O
background	O
,	O
but	O
not	O
C57Bl	O
/	O
6	O
or	O
129	O
/	O
Sv	O
,	O
suggests	O
a	O
genetic	O
predisposition	O
toward	O
mammary	O
tumorigenesis	O
.	O

Therefore	O
,	O
the	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
+	I
/	I
-	I
)	I
mice	O
provide	O
a	O
unique	O
model	O
for	O
the	O
study	O
of	O
breast	O
cancer	O
in	O
Li	O
-	O
Fraumeni	O
syndrome	O
.	O

These	O
results	O
demonstrate	O
the	O
critical	O
role	O
that	O
the	O
p53	B
tumor	O
suppressor	O
gene	O
plays	O
in	O
preventing	O
tumorigenesis	O
in	O
the	O
mammary	O
gland	O
.	O

Nonobese	O
diabetic	O
(	O
NOD	O
)	O
mice	O
spontaneously	O
develop	O
diabetes	O
as	O
a	O
consequence	O
of	O
an	O
autoimmune	O
process	O
that	O
can	O
be	O
inhibited	O
by	O
immunotherapy	O
with	O
the	O
60-kDa	O
heat	O
shock	O
protein	O
(	O
hsp60	B
)	O
,	O
with	O
its	O
mycobacterial	O
counterpart	O
65-kDa	O
(	O
hsp65	O
)	O
,	O
or	O
with	O
other	O
Ags	O
such	O
as	O
insulin	O
and	O
glutamic	O
acid	O
decarboxylase	O
(	O
GAD	O
)	O
.	O

Microbial	O
infection	O
and	O
innate	O
signaling	O
via	O
LPS	O
or	O
CpG	O
motifs	O
can	O
also	O
inhibit	O
the	O
spontaneous	O
diabetogenic	O
process	O
.	O

In	O
addition	O
to	O
the	O
spontaneous	O
disease	O
,	O
however	O
,	O
NOD	O
mice	O
can	O
develop	O
a	O
more	O
robust	O
cyclophosphamide	O
-	O
accelerated	O
diabetes	O
(	O
CAD	O
)	O
.	O

In	O
this	O
work	O
,	O
we	O
studied	O
the	O
effect	O
on	O
CAD	O
of	O
DNA	O
vaccination	O
with	O
constructs	O
encoding	O
the	O
Ags	O
human	O
hsp60	B
(	O
phsp60	O
)	O
or	O
mycobacterial	O
hsp65	O
(	O
phsp65	O
)	O
.	O

Vaccination	O
with	O
phsp60	O
protected	O
NOD	O
mice	O
from	O
CAD	O
.	O

In	O
contrast	O
,	O
vaccination	O
with	O
phsp65	O
,	O
with	O
an	O
empty	O
vector	O
,	O
or	O
with	O
a	O
CpG	O
-	O
positive	O
oligonucleotide	O
was	O
not	O
effective	O
,	O
suggesting	O
that	O
the	O
efficacy	O
of	O
the	O
phsp60	O
construct	O
might	O
be	O
based	O
on	O
regulatory	O
hsp60	B
epitopes	O
not	O
shared	O
with	O
its	O
mycobacterial	O
counterpart	O
,	O
hsp65	O
.	O

Vaccination	O
with	O
phsp60	O
modulated	O
the	O
T	O
cell	O
responses	O
to	O
hsp60	B
and	O
also	O
to	O
the	O
GAD	O
and	O
insulin	O
autoantigens	O
;	O
T	O
cell	O
proliferative	O
responses	O
were	O
significantly	O
reduced	O
,	O
and	O
the	O
pattern	O
of	O
cytokine	O
secretion	O
to	O
hsp60	B
,	O
GAD	O
,	O
and	O
insulin	O
showed	O
an	O
increase	O
in	O
IL-10	B
and	O
IL-5	B
secretion	O
and	O
a	O
decrease	O
in	O
IFN	B
-	I
gamma	I
secretion	O
,	O
compatible	O
with	O
a	O
shift	O
from	O
a	O
Th1-like	O
toward	O
a	O
Th2-like	O
autoimmune	O
response	O
.	O

Our	O
results	O
extend	O
the	O
role	O
of	O
specific	O
hsp60	B
immunomodulation	O
in	O
the	O
control	O
of	O
beta	O
cell	O
autoimmunity	O
and	O
demonstrate	O
that	O
immunoregulatory	O
networks	O
activated	O
by	O
specific	O
phsp60	O
vaccination	O
can	O
spread	O
to	O
other	O
Ags	O
targeted	O
during	O
the	O
progression	O
of	O
diabetes	O
,	O
like	O
insulin	O
and	O
GAD	O
.	O

Age	O
-	O
related	O
changes	O
in	O
T	O
cell	O
subsets	O
were	O
examined	O
in	O
intestinal	O
intraepithelial	O
lymphocytes	O
(	O
i	O
-	O
IEL	O
)	O
,	O
which	O
contain	O
unique	O
T	O
cells	O
differentiating	O
extrathymically	O
.	O

In	O
2-month	O
-	O
old	O
mice	O
bred	O
under	O
conventional	O
condition	O
,	O
i	O
-	O
IEL	O
consisted	O
of	O
a	O
large	O
number	O
of	O
CD4-CD8	O
alpha	O
/	O
alpha+	O
cells	O
bearing	O
either	O
T	O
cell	O
receptor	O
(	O
TcR	O
)	O
alpha	O
/	O
beta	O
or	O
TcR	O
gamma	O
/	O
delta	O
and	O
only	O
a	O
few	O
CD4+CD8	O
alpha-	O
cells	O
.	O

In	O
aged	O
mice	O
(	O
6	O
months	O
old	O
and	O
24	O
months	O
old	O
)	O
,	O
unique	O
CD4+CD8	O
alpha	O
/	O
alpha+	O
i	O
-	O
IEL	O
bearing	O
TcR	B
alpha	I
/	O
beta	O
increased	O
in	O
number	O
and	O
conversely	O
the	O
proportion	O
of	O
TcR	O
gamma	O
/	O
delta+	O
i	O
-	O
IEL	O
was	O
decreased	O
.	O

Such	O
an	O
increase	O
in	O
number	O
of	O
CD4+CD8	O
alpha	O
/	O
alpha+	O
cells	O
was	O
detected	O
in	O
i	O
-	O
IEL	O
from	O
aged	O
(	O
14-months	O
old	O
)	O
nude	O
mice	O
,	O
but	O
not	O
in	O
aged	O
(	O
14	O
months	O
old	O
)	O
germ	O
-	O
free	O
mice	O
,	O
suggesting	O
that	O
a	O
significant	O
fraction	O
of	O
TcR	B
alpha	I
/	O
beta	O
T	O
cells	O
such	O
as	O
CD4+CD8	O
alpha+	O
i	O
-	O
IEL	O
can	O
develop	O
along	O
an	O
extrathymic	O
pathway	O
under	O
the	O
influence	O
of	O
intestinal	O
microflora	O
with	O
age	O
.	O

BACKGROUND	O
:	O
Tumor	B
necrosis	I
factor	I
-	I
alpha	I
(	O
TNF	B
-	I
alpha	I
)	O
is	O
chronically	O
elevated	O
in	O
the	O
adipose	O
tissue	O
from	O
obese	O
humans	O
and	O
mice	O
.	O

This	O
increase	O
in	O
TNF	B
-	I
alpha	I
contributes	O
to	O
the	O
insulin	O
resistance	O
,	O
elevated	O
plasminogen	O
activator	O
inhibitor-1	O
(	O
PAI-1	B
)	O
levels	O
,	O
and	O
cardiovascular	O
complications	O
associated	O
with	O
obesity	O
and	O
noninsulin	O
-	O
dependent	O
diabetes	O
(	O
NIDDM	O
)	O
.	O

PAI-1	B
gene	O
expression	O
in	O
adipose	O
tissue	O
is	O
also	O
stimulated	O
by	O
transforming	O
growth	O
factor	O
-	O
beta	O
(	O
TGF	O
-	O
beta	O
)	O
.	O

Experiments	O
were	O
performed	O
to	O
determine	O
whether	O
TGF	O
-	O
beta	O
is	O
regulated	O
by	O
TNF	B
-	I
alpha	I
and	O
elevated	O
in	O
obesity	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
The	O
concentration	O
of	O
TGF	O
-	O
beta	O
and	O
PAI-1	B
mRNA	O
in	O
murine	O
adipose	O
tissue	O
and	O
cultured	O
3T3-L1	O
adipocytes	O
was	O
determined	O
by	O
quantitative	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
,	O
and	O
the	O
cellular	O
localization	O
of	O
these	O
molecules	O
was	O
evaluated	O
using	O
in	O
situ	O
hybridization	O
and	O
cell	O
fractionation	O
.	O

Total	O
TGF	O
-	O
beta	O
protein	O
was	O
determined	O
by	O
employing	O
an	O
ELISA	O
assay	O
.	O

RESULTS	O
:	O
TGF	O
-	O
beta	O
mRNA	O
and	O
protein	O
were	O
increased	O
in	O
the	O
adipose	O
tissue	O
from	O
two	O
different	O
strains	O
of	O
genetically	O
obese	O
mice	O
(	O
i.e.	O
,	O
ob	O
/	O
ob	O
and	O
db	O
/	O
db	O
)	O
,	O
compared	O
with	O
their	O
lean	O
counterparts	O
.	O

This	O
increase	O
in	O
TGF	O
-	O
beta	O
may	O
result	O
from	O
TNF	B
-	I
alpha	I
since	O
TNF	B
-	I
alpha	I
increased	O
TGF	O
-	O
beta	O
mRNA	O
expression	O
in	O
the	O
adipose	O
tissue	O
of	O
lean	O
mice	O
and	O
stimulated	O
TGF	O
-	O
beta	O
production	O
by	O
cultured	O
adipocytes	O
.	O

Administration	O
of	O
TGF	O
-	O
beta	O
increased	O
PAI-1	B
antigen	O
in	O
the	O
plasma	O
and	O
PAI-1	B
mRNA	O
in	O
the	O
adipocytes	O
of	O
lean	O
mice	O
,	O
and	O
enhanced	O
the	O
rate	O
of	O
PAI-1	B
synthesis	O
by	O
adipocytes	O
in	O
vitro	O
.	O

CONCLUSIONS	O
:	O
TNF	B
-	I
alpha	I
contributes	O
to	O
the	O
elevated	O
TGF	O
-	O
beta	O
expression	O
demonstrated	O
in	O
the	O
adipose	O
tissue	O
of	O
obese	O
mice	O
.	O

A	O
potential	O
role	O
for	O
TGF	O
-	O
beta	O
in	O
the	O
increased	O
PAI-1	B
and	O
vascular	O
pathologies	O
associated	O
with	O
obesity	O
/	O
NIDDM	O
is	O
suggested	O
.	O

These	O
studies	O
examined	O
the	O
importance	O
of	O
phospholipase	O
Cbeta	O
(	O
PLCbeta	O
)	O
in	O
the	O
calcium	O
responses	O
of	O
pituitary	O
cells	O
using	O
PLCbeta3	O
knockout	O
mice	O
.	O

Pituitary	O
tissue	O
from	O
wild	O
-	O
type	O
mice	O
contained	O
PLCbeta1	O
and	O
PLCbeta3	O
but	O
not	O
PLCbeta2	O
or	O
PLCbeta4	O
.	O

Both	O
Galphaq	B
/	O
11	O
and	O
Gbetagamma	O
can	O
activate	O
PLCbeta3	O
,	O
whereas	O
only	O
Galphaq	B
/	O
11	O
activates	O
PLCss1	O
effectively	O
.	O

In	O
knockout	O
mice	O
,	O
PLCbeta3	O
was	O
absent	O
,	O
PLCbeta1	O
was	O
not	O
up	O
-	O
regulated	O
,	O
and	O
PLCbeta2	O
and	O
PLCbeta4	O
were	O
not	O
expressed	O
.	O

Since	O
somatostatin	B
inhibited	O
influx	O
of	O
extracellular	O
calcium	O
in	O
pituitary	O
cells	O
from	O
wild	O
-	O
type	O
and	O
PLCbeta3	O
knockout	O
mice	O
,	O
the	O
somatostatin	B
signal	O
pathway	O
was	O
intact	O
.	O

However	O
,	O
somatostatin	B
failed	O
to	O
increase	O
intracellular	O
calcium	O
in	O
pituitary	O
cells	O
from	O
either	O
wild	O
-	O
type	O
or	O
knockout	O
mice	O
under	O
a	O
variety	O
of	O
conditions	O
,	O
indicating	O
that	O
it	O
did	O
not	O
stimulate	O
PLCbeta3	O
.	O

In	O
contrast	O
,	O
somatostatin	B
increased	O
intracellular	O
calcium	O
in	O
aortic	O
smooth	O
muscle	O
cells	O
from	O
wild	O
-	O
type	O
mice	O
,	O
although	O
it	O
evoked	O
no	O
calcium	O
response	O
in	O
cells	O
from	O
PLCbeta3	O
knockout	O
animals	O
These	O
results	O
show	O
that	O
somatostatin	B
,	O
like	O
other	O
Gi	O
/	O
Go	O
-	O
linked	O
hormones	O
,	O
can	O
stimulate	O
a	O
calcium	O
transient	O
by	O
activating	O
PLCbeta3	O
through	O
Gbetagamma	O
,	O
but	O
this	O
response	O
does	O
not	O
normally	O
occur	O
in	O
pituitary	O
cells	O
.	O

The	O
densities	O
of	O
Gi	O
and	O
Go	O
,	O
as	O
well	O
as	O
the	O
relative	O
concentrations	O
of	O
PLCbeta1	O
and	O
PLCbeta3	O
,	O
were	O
similar	O
in	O
cells	O
that	O
responded	O
to	O
somatostatin	B
with	O
an	O
increase	O
in	O
calcium	O
and	O
pituitary	O
cells	O
.	O

Calcium	O
responses	O
to	O
1	O
nM	O
and	O
1	O
microM	O
TRH	B
and	O
GnRH	B
were	O
identical	O
in	O
pituitary	O
cells	O
from	O
wild	O
-	O
type	O
and	O
PLCbeta3	O
knockout	O
mice	O
,	O
as	O
were	O
responses	O
to	O
other	O
Gq	B
-	O
linked	O
agonists	O
.	O

These	O
results	O
show	O
that	O
in	O
pituitary	O
cells	O
,	O
PLCbeta1	O
is	O
sufficient	O
to	O
transmit	O
signals	O
from	O
Gq	B
-	O
coupled	O
hormones	O
,	O
whereas	O
PLCbeta3	O
is	O
required	O
for	O
the	O
calcium	O
-	O
mobilizing	O
actions	O
of	O
somatostatin	B
observed	O
in	O
smooth	O
muscle	O
cells	O
.	O

Mitochondrial	O
uncoupling	O
proteins	O
have	O
been	O
implicated	O
in	O
the	O
maintenance	O
of	O
metabolic	O
rate	O
and	O
adaptational	O
thermoregulation	O
.	O

We	O
recently	O
reported	O
the	O
identification	O
of	O
a	O
brain	O
-	O
specific	O
mitochondrial	O
uncoupling	O
protein	O
homologue	O
,	O
UCP4	O
.	O

Here	O
we	O
characterized	O
another	O
newly	O
described	O
member	O
of	O
the	O
uncoupling	O
protein	O
family	O
,	O
termed	O
UCP5	B
(	O
also	O
called	O
BMCP1	B
)	O
.	O

UCP5	B
transcripts	O
are	O
present	O
in	O
multiple	O
human	O
and	O
mouse	O
tissues	O
,	O
with	O
an	O
especially	O
high	O
abundance	O
in	O
the	O
brain	O
and	O
testis	O
.	O

Expression	O
of	O
UCP5	B
in	O
mammalian	O
cells	O
reduces	O
the	O
mitochondrial	O
membrane	O
potential	O
.	O

Multiple	O
isoforms	O
of	O
UCP5	B
were	O
identified	O
and	O
exhibited	O
tissue	O
-	O
specific	O
distribution	O
and	O
different	O
potency	O
in	O
reduction	O
of	O
membrane	O
potential	O
.	O

Furthermore	O
,	O
the	O
mRNA	O
abundance	O
of	O
both	O
UCP4	O
and	O
UCP5	B
is	O
modulated	O
by	O
nutritional	O
status	O
or	O
temperature	O
in	O
a	O
tissue	O
-	O
specific	O
manner	O
in	O
mice	O
.	O

Brain	O
UCP4	O
and	O
UCP5	B
mRNA	O
transcripts	O
rose	O
by	O
1.5-	O
and	O
1.7-fold	O
,	O
respectively	O
,	O
and	O
liver	O
UCP5	B
expression	O
increased	O
by	O
1.8-fold	O
in	O
response	O
to	O
acute	O
cold	O
exposure	O
.	O

A	O
high	O
-	O
fat	O
diet	O
increased	O
UCP5	B
mRNA	O
in	O
liver	O
by	O
1.6-fold	O
selectively	O
in	O
the	O
obesity	O
-	O
resistant	O
A	O
/	O
J	O
but	O
not	O
in	O
the	O
obesity	O
-	O
prone	O
C57BL	O
/	O
6J	O
mouse	O
strain	O
.	O

Liver	O
UCP5	B
expression	O
decreased	O
significantly	O
with	O
a	O
24	O
h	O
fast	O
and	O
was	O
restored	O
to	O
the	O
normal	O
level	O
after	O
refeeding	O
.	O

In	O
contrast	O
,	O
brain	O
transcripts	O
for	O
both	O
genes	O
were	O
not	O
significantly	O
altered	O
by	O
fasting	O
or	O
high	O
-	O
fat	O
diet	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
the	O
notion	O
that	O
UCP4	O
and	O
UCP5	B
may	O
be	O
involved	O
in	O
tissue	O
-	O
specific	O
thermoregulation	O
and	O
metabolic	O
changes	O
associated	O
with	O
nutritional	O
status	O
.	O

In	O
this	O
study	O
we	O
investigate	O
the	O
roles	O
of	O
the	O
organizer	O
factors	O
chordin	B
and	O
noggin	B
,	O
which	O
are	O
dedicated	O
antagonists	O
of	O
the	O
bone	O
morphogenetic	O
proteins	O
(	O
BMPs	O
)	O
,	O
in	O
formation	O
of	O
the	O
mammalian	O
head	O
.	O

The	O
mouse	O
chordin	B
and	O
noggin	B
genes	O
(	O
Chrd	B
and	O
Nog	B
)	O
are	O
expressed	O
in	O
the	O
organizer	O
(	O
the	O
node	O
)	O
and	O
its	O
mesendodermal	O
derivatives	O
,	O
including	O
the	O
prechordal	O
plate	O
,	O
an	O
organizing	O
center	O
for	O
rostral	O
development	O
.	O

They	O
are	O
also	O
expressed	O
at	O
lower	O
levels	O
in	O
and	O
around	O
the	O
anterior	O
neural	O
ridge	O
,	O
another	O
rostral	O
organizing	O
center	O
.	O

To	O
elucidate	O
roles	O
of	O
Chrd	B
and	O
Nog	B
that	O
are	O
masked	O
by	O
the	O
severe	O
phenotype	O
and	O
early	O
lethality	O
of	O
the	O
double	O
null	O
,	O
we	O
have	O
characterized	O
embryos	O
of	O
the	O
genotype	O
Chrd	B
(	I
-	I
/	I
-	I
)	I
;Nog	O
(	B
+	I
/	I
-	I
)	I
.	O

These	O
animals	O
display	O
partially	O
penetrant	O
neonatal	O
lethality	O
,	O
with	O
defects	O
restricted	O
to	O
the	O
head	O
.	O

The	O
variable	O
phenotypes	O
include	O
cyclopia	O
,	O
holoprosencephaly	O
,	O
and	O
rostral	O
truncations	O
of	O
the	O
brain	O
and	O
craniofacial	O
skeleton	O
.	O

In	O
situ	O
hybridization	O
reveals	O
a	O
loss	O
of	O
SHH	B
expression	O
and	O
signaling	O
by	O
the	O
prechordal	O
plate	O
,	O
and	O
a	O
decrease	O
in	O
FGF8	B
expression	O
and	O
signaling	O
by	O
the	O
anterior	O
neural	O
ridge	O
at	O
the	O
five	O
-	O
somite	O
stage	O
.	O

Defective	O
Chrd	B
(	I
-	I
/	I
-	I
)	I
;Nog	O
(	B
+	I
/	I
-	I
)	I
embryos	O
exhibit	O
reduced	O
cell	O
proliferation	O
in	O
the	O
rostral	O
neuroepithelium	O
at	O
10	O
somites	O
,	O
followed	O
by	O
increased	O
cell	O
death	O
1	O
day	O
later	O
.	O

Because	O
these	O
phenotypes	O
result	O
from	O
reduced	O
levels	O
of	O
BMP	O
antagonists	O
,	O
we	O
hypothesized	O
that	O
they	O
are	O
due	O
to	O
increased	O
BMP	O
activity	O
.	O

Ectopic	O
application	O
of	O
BMP2	B
to	O
wild	O
-	O
type	O
cephalic	O
explants	O
results	O
in	O
decreased	O
FGF8	B
and	O
SHH	B
expression	O
in	O
rostral	O
tissue	O
,	O
suggesting	O
that	O
the	O
decreased	O
expression	O
of	O
FGF8	B
and	O
SHH	B
observed	O
in	O
vivo	O
is	O
due	O
to	O
ectopic	O
BMP	O
activity	O
.	O

Cephalic	O
explants	O
isolated	O
from	O
Chrd;Nog	B
double	O
mutant	O
embryos	O
show	O
an	O
increased	O
sensitivity	O
to	O
ectopic	O
BMP	O
protein	O
,	O
further	O
supporting	O
the	O
hypothesis	O
that	O
these	O
mutants	O
are	O
deficient	O
in	O
BMP	O
antagonism	O
.	O

These	O
results	O
indicate	O
that	O
the	O
BMP	O
antagonists	O
chordin	B
and	O
noggin	B
promote	O
the	O
inductive	O
and	O
trophic	O
activities	O
of	O
rostral	O
organizing	O
centers	O
in	O
early	O
development	O
of	O
the	O
mammalian	O
head	O
.	O

Cyclic	O
AMP	O
is	O
hydrolyzed	O
by	O
members	O
of	O
at	O
least	O
eight	O
classes	O
of	O
cyclic	O
nucleotide	O
phosphodiesterases	O
(	O
PDEs	O
)	O
.	O

Although	O
it	O
has	O
been	O
reported	O
that	O
cyclic	O
AMP	O
PDE	O
activity	O
in	O
mammalian	O
tissues	O
can	O
be	O
inhibited	O
by	O
benzodiazepines	O
,	O
it	O
has	O
not	O
been	O
conclusively	O
demonstrated	O
that	O
members	O
of	O
the	O
class	O
of	O
cyclic	O
AMP	O
-	O
specific	O
,	O
rolipram	O
-	O
inhibitable	O
PDEs	O
(	O
PDE4s	O
)	O
are	O
targets	O
for	O
these	O
drugs	O
.	O

Moreover	O
,	O
no	O
PDE4s	O
expressed	O
in	O
mice	O
have	O
been	O
characterized	O
.	O

To	O
address	O
these	O
issues	O
,	O
we	O
isolated	O
two	O
cDNAs	O
representing	O
homologues	O
of	O
PDE4A1	O
and	O
PDE4B3	O
from	O
a	O
mouse	O
brain	O
library	O
.	O

After	O
transient	O
transfection	O
in	O
human	O
embryonic	O
kidney	O
(	O
HEK	O
)	O
293	O
cells	O
,	O
the	O
mouse	O
PDEs	O
hydrolyzed	O
cyclic	O
AMP	O
with	O
a	O
low	O
K	O
(	O
m	O
)	O
and	O
were	O
inhibited	O
by	O
rolipram	O
;	O
both	O
are	O
properties	O
typical	O
of	O
other	O
mammalian	O
PDE4	O
enzymes	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
diazepam	O
inhibited	O
cyclic	O
AMP	O
hydrolysis	O
by	O
the	O
mouse	O
PDE4	O
subtypes	O
.	O

Interestingly	O
,	O
PDE4B	B
was	O
significantly	O
more	O
sensitive	O
to	O
inhibition	O
by	O
both	O
rolipram	O
and	O
diazepam	O
than	O
the	O
PDE4A	B
subtype	O
.	O

This	O
is	O
the	O
first	O
demonstration	O
that	O
recombinantly	O
expressed	O
PDE4s	O
are	O
inhibited	O
by	O
diazepam	O
,	O
and	O
should	O
facilitate	O
future	O
studies	O
with	O
mouse	O
models	O
of	O
depression	O
and	O
anxiety	O
.	O

The	O
renin	O
-	O
angiotensin	O
system	O
is	O
normally	O
subject	O
to	O
servo	O
control	O
mechanisms	O
that	O
suppress	O
plasma	O
renin	O
levels	O
in	O
response	O
to	O
increased	O
blood	O
pressure	O
and	O
increase	O
plasma	O
renin	O
levels	O
when	O
blood	O
pressure	O
falls	O
.	O

In	O
most	O
species	O
,	O
renin	O
is	O
rate	O
limiting	O
,	O
and	O
angiotensinogen	B
circulates	O
at	O
a	O
concentration	O
close	O
to	O
the	O
Km	O
,	O
so	O
varying	O
the	O
concentration	O
of	O
either	O
can	O
affect	O
the	O
rate	O
of	O
angiotensin	O
formation	O
.	O

However	O
,	O
only	O
the	O
plasma	O
renin	O
level	O
responds	O
to	O
changes	O
in	O
blood	O
pressure	O
and	O
sodium	O
balance	O
to	O
maintain	O
blood	O
pressure	O
homeostasis	O
.	O

Therefore	O
,	O
the	O
high	O
plasma	O
human	O
renin	O
levels	O
and	O
the	O
hypertension	O
of	O
mice	O
and	O
rats	O
containing	O
both	O
human	O
renin	O
and	O
angiotensinogen	B
transgenes	O
indicate	O
inappropriate	O
regulation	O
of	O
renin	O
and	O
blood	O
pressure	O
.	O

These	O
anomalies	O
led	O
us	O
to	O
develop	O
new	O
lines	O
of	O
transgenic	O
mice	O
with	O
a	O
longer	O
human	O
renin	O
gene	O
fragment	O
(	O
45	O
kb	O
)	O
than	O
earlier	O
lines	O
(	O
13	O
to	O
15	O
kb	O
)	O
.	O

Unlike	O
their	O
predecessors	O
,	O
the	O
45-kb	O
hREN	O
mice	O
secrete	O
human	O
renin	O
only	O
from	O
the	O
kidneys	O
,	O
and	O
both	O
the	O
human	O
and	O
mouse	O
renins	O
respond	O
appropriately	O
to	O
physiological	O
stimuli	O
.	O

To	O
determine	O
whether	O
blood	O
pressure	O
is	O
also	O
regulated	O
appropriately	O
,	O
we	O
crossed	O
these	O
new	O
45-kb	O
hREN	O
mice	O
with	O
mice	O
containing	O
the	O
human	O
angiotensinogen	B
gene	O
.	O

All	O
doubly	O
transgenic	O
mice	O
were	O
normotensive	O
like	O
their	O
singly	O
transgenic	O
and	O
nontransgenic	O
littermates	O
.	O

Moreover	O
,	O
among	O
doubly	O
transgenic	O
mice	O
,	O
both	O
human	O
and	O
mouse	O
plasma	O
renin	O
concentrations	O
were	O
suppressed	O
relative	O
to	O
the	O
singly	O
transgenic	O
45-kb	O
hREN	O
mice	O
.	O

These	O
findings	O
demonstrate	O
the	O
importance	O
of	O
appropriate	O
cell	O
and	O
tissue	O
specificity	O
of	O
gene	O
expression	O
in	O
constructing	O
transgenic	O
models	O
and	O
affirm	O
the	O
pivotal	O
role	O
played	O
by	O
renal	O
renin	O
secretion	O
in	O
blood	O
pressure	O
control	O
.	O

Endoglin	B
is	O
an	O
integral	O
membrane	O
glycoprotein	O
predominantly	O
expressed	O
on	O
human	O
endothelial	O
cells	O
and	O
recently	O
shown	O
to	O
bind	O
transforming	O
growth	O
factor	O
-	O
beta	O
1	O
(	O
TGF	O
beta	O
1	O
)	O
with	O
high	O
affinity	O
.	O

We	O
now	O
report	O
the	O
cloning	O
and	O
sequencing	O
of	O
a	O
full	O
-	O
length	O
murine	O
endoglin	B
complementary	O
DNA	O
of	O
2902	O
base	O
pairs	O
which	O
hybridizes	O
specifically	O
with	O
a	O
single	O
messenger	O
RNA	O
(	O
mRNA	O
)	O
species	O
.	O

The	O
polypeptide	O
of	O
653	O
amino	O
acids	O
has	O
an	O
overall	O
identity	O
of	O
72	O
%	O
with	O
human	O
and	O
porcine	O
endoglin	B
.	O

The	O
transmembrane	O
and	O
cytoplasmic	O
domains	O
of	O
all	O
three	O
proteins	O
differ	O
by	O
two	O
to	O
four	O
amino	O
acids	O
and	O
are	O
70	O
%	O
identical	O
to	O
the	O
corresponding	O
regions	O
of	O
the	O
TGF	O
beta	O
binding	O
protein	O
,	O
betaglycan	B
.	O

Relative	O
levels	O
of	O
murine	O
endoglin	B
mRNA	O
were	O
estimated	O
by	O
polymerase	O
chain	O
reaction	O
and	O
found	O
to	O
be	O
high	O
in	O
ovary	O
and	O
uterus	O
,	O
intermediate	O
in	O
heart	O
and	O
muscle	O
,	O
and	O
low	O
in	O
placenta	O
and	O
spleen	O
.	O

In	O
situ	O
hybridization	O
and	O
immunofluorescence	O
confirmed	O
that	O
murine	O
endoglin	B
,	O
like	O
its	O
human	O
counterpart	O
,	O
is	O
present	O
in	O
blood	O
vessels	O
and	O
capillaries	O
in	O
all	O
tissues	O
examined	O
.	O

In	O
addition	O
,	O
the	O
stromal	O
cells	O
in	O
the	O
connective	O
tissue	O
of	O
intestine	O
,	O
stomach	O
,	O
heart	O
,	O
muscle	O
,	O
uterus	O
,	O
ovary	O
,	O
and	O
testis	O
were	O
strongly	O
and	O
specifically	O
reactive	O
with	O
complementary	O
RNA	O
probes	O
and	O
with	O
a	O
polyclonal	O
antibody	O
to	O
endoglin	B
;	O
epithelial	O
cell	O
layers	O
were	O
distinctly	O
unreactive	O
.	O

This	O
distribution	O
is	O
similar	O
to	O
that	O
of	O
extracellular	O
TGF	O
beta	O
1	O
,	O
particularly	O
in	O
heart	O
and	O
uterus	O
,	O
and	O
suggests	O
that	O
endoglin	B
on	O
stromal	O
fibroblast	O
-	O
like	O
cells	O
might	O
be	O
regulating	O
access	O
of	O
TGF	O
beta	O
1	O
to	O
the	O
signaling	O
receptor	O
complex	O
.	O

NCTC-2071	O
fibroblasts	O
in	O
culture	O
were	O
shown	O
to	O
express	O
high	O
levels	O
of	O
endoglin	B
mRNA	O
by	O
polymerase	O
chain	O
reaction	O
.	O

After	O
chemical	O
cross	O
-	O
linking	O
with	O
[	O
125I	O
]	O
TGF	O
beta	O
1	O
and	O
immunoprecipitation	O
with	O
the	O
polyclonal	O
antihuman	O
endoglin	B
serum	O
,	O
a	O
radiolabeled	O
band	O
of	O
mol	O
wt	O
180,000	O
corresponding	O
to	O
dimeric	O
endoglin	B
was	O
observed	O
under	O
nonreducing	O
conditions	O
,	O
whereas	O
a	O
single	O
band	O
of	O
mol	O
wt	O
90,000	O
was	O
seen	O
under	O
reducing	O
conditions	O
.	O

Thus	O
murine	O
fibroblast	O
endoglin	B
is	O
capable	O
of	O
binding	O
TGF	O
beta	O
1	O
.	O

Future	O
studies	O
should	O
establish	O
the	O
specialized	O
role	O
of	O
endoglin	B
in	O
the	O
TGF	O
beta	O
receptor	O
complex	O
of	O
endothelial	O
and	O
stromal	O
cells	O
.	O

The	O
BCL-2	B
family	O
has	O
various	O
pairs	O
of	O
antagonist	O
and	O
agonist	O
proteins	O
that	O
regulate	O
apoptosis	O
.	O

Whether	O
their	O
function	O
is	O
interdependent	O
is	O
uncertain	O
.	O

Using	O
a	O
genetic	O
approach	O
to	O
address	O
this	O
question	O
,	O
we	O
utilized	O
gain-	O
and	O
loss	O
-	O
of	O
-	O
function	O
models	O
of	O
Bcl-2	B
and	O
Bax	B
and	O
found	O
that	O
apoptosis	O
and	O
thymic	O
hypoplasia	O
characteristic	O
of	O
Bcl-2-deficient	B
mice	O
are	O
largely	O
absent	O
in	O
mice	O
also	O
deficient	O
in	O
Bax	B
.	O

A	O
single	O
copy	O
of	O
Bax	B
promoted	O
apoptosis	O
in	O
the	O
absence	O
of	O
Bcl-2	B
.	O

In	O
contrast	O
,	O
overexpression	O
of	O
Bcl-2	B
still	O
repressed	O
apoptosis	O
in	O
the	O
absence	O
of	O
Bax	B
.	O

While	O
an	O
in	O
vivo	O
competition	O
exists	O
between	O
Bax	B
and	O
Bcl-2	B
,	O
each	O
is	O
able	O
to	O
regulate	O
apoptosis	O
independently	O
.	O

Major	O
histocompatibility	O
complex	O
class	O
II	O
positive	O
cells	O
,	O
namely	O
dendritic	O
cells	O
,	O
monocytes	O
/	O
macrophages	O
,	O
and	O
B	O
cells	O
,	O
are	O
categorized	O
as	O
antigen	O
-	O
presenting	O
cells	O
.	O

Dendritic	O
cells	O
,	O
so	O
-	O
called	O
professional	O
antigen	O
-	O
presenting	O
cells	O
,	O
use	O
distinct	O
sets	O
of	O
surface	O
receptors	O
before	O
and	O
after	O
maturation	O
:	O
those	O
to	O
capture	O
antigens	O
and	O
those	O
to	O
interact	O
with	O
T	O
cells	O
,	O
respectively	O
.	O

But	O
there	O
remain	O
many	O
surface	O
molecules	O
whose	O
functions	O
are	O
still	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
isolated	O
dendritic	B
cell	I
immunoreceptor	I
from	O
mouse	O
bone	O
-	O
marrow	O
-	O
derived	O
mature	O
dendritic	O
cells	O
.	O

Dendritic	B
cell	I
immunoreceptor	I
is	O
a	O
recently	O
reported	O
C	O
-	O
type	O
lectin	O
receptor	O
characteristic	O
with	O
cytoplasmic	O
immunoreceptor	O
tyrosine	O
-	O
based	O
inhibitory	O
motif	O
.	O

Expression	O
of	O
mouse	O
dendritic	B
cell	I
immunoreceptor	I
mRNA	O
was	O
observed	O
specifically	O
in	O
spleen	O
and	O
lymph	O
node	O
,	O
slightly	O
increased	O
with	O
dendritic	O
cell	O
maturation	O
during	O
in	O
vitro	O
culture	O
of	O
bone	O
marrow	O
cells	O
,	O
and	O
was	O
not	O
detected	O
in	O
cultured	O
natural	O
killer	O
cells	O
.	O

Surface	O
expression	O
of	O
mouse	O
dendritic	B
cell	I
immunoreceptor	I
protein	O
was	O
observed	O
in	O
splenic	O
antigen	O
-	O
presenting	O
cells	O
including	O
B	O
cells	O
,	O
monocytes	O
/	O
macrophages	O
,	O
and	O
dendritic	O
cells	O
,	O
but	O
not	O
in	O
T	O
cells	O
.	O

To	O
reveal	O
the	O
downregulating	O
capacity	O
of	O
dendritic	B
cell	I
immunoreceptor	I
in	O
antigen	O
-	O
presenting	O
cells	O
,	O
the	O
change	O
of	O
B	O
-	O
cell	O
-	O
receptor	O
-	O
mediated	O
signals	O
after	O
coligation	O
with	O
a	O
chimeric	O
Fcgamma	O
receptor	O
IIB	O
containing	O
the	O
cytoplasmic	O
portion	O
of	O
mouse	O
dendritic	B
cell	I
immunoreceptor	I
was	O
examined	O
.	O

As	O
a	O
result	O
,	O
we	O
detected	O
two	O
distinct	O
inhibitory	O
effects	O
of	O
cytoplasmic	O
dendritic	B
cell	I
immunoreceptor	I
minus	O
sign	O
inhibition	O
of	O
B	O
-	O
cell	O
-	O
receptor	O
-	O
mediated	O
Ca2	O
+	O
mobilization	O
and	O
protein	O
tyrosine	O
phosphorylation	O
minus	O
sign	O
and	O
both	O
of	O
these	O
effects	O
required	O
the	O
tyrosine	O
residue	O
inside	O
the	O
immunoreceptor	O
tyrosine	O
-	O
based	O
inhibitory	O
motif	O
.	O

This	O
report	O
presents	O
immunoreceptor	O
tyrosine	O
-	O
based	O
inhibitory	O
motif	O
-	O
dependent	O
negative	O
regulatory	O
function	O
of	O
dendritic	O
cell	O
immunoreceptors	O
.	O

In	O
conclusion	O
,	O
mouse	O
dendritic	B
cell	I
immunoreceptor	I
expressed	O
on	O
antigen	O
-	O
presenting	O
cells	O
can	O
exert	O
two	O
distinct	O
inhibitory	O
signals	O
depending	O
on	O
its	O
immunoreceptor	O
tyrosine	O
-	O
based	O
inhibitory	O
motif	O
tyrosine	O
residue	O
.	O

We	O
have	O
used	O
a	O
quantitative	O
RT	O
-	O
PCR	O
approach	O
to	O
determine	O
the	O
levels	O
of	O
Brn3a	B
and	O
Brn3b	B
POU	O
domain	O
transcription	O
factor	O
mRNAs	O
in	O
the	O
developing	O
mouse	O
trigeminal	O
ganglion	O
from	O
E10	O
to	O
E18	O
.	O

Using	O
low	O
density	O
neuronal	O
cultures	O
,	O
we	O
have	O
shown	O
that	O
NT-3	B
can	O
regulate	O
the	O
expression	O
of	O
Brn3a	B
mRNA	O
in	O
trigeminal	O
neurons	O
during	O
the	O
periods	O
that	O
they	O
are	O
differentiating	O
and	O
innervating	O
their	O
peripheral	O
and	O
central	O
targets	O
.	O

In	O
contrast	O
to	O
Brn3a	B
,	O
Brn3b	B
mRNA	O
is	O
expressed	O
at	O
extremely	O
low	O
levels	O
in	O
the	O
early	O
trigeminal	O
ganglion	O
.	O

Trigeminal	O
neurons	O
from	O
early	O
ganglia	O
express	O
low	O
levels	O
of	O
Brn3b	B
mRNA	O
in	O
culture	O
and	O
do	O
not	O
up	O
-	O
regulate	O
Brn3b	B
mRNA	O
in	O
response	O
to	O
a	O
number	O
of	O
growth	O
factors	O
and	O
experimental	O
conditions	O
.	O

However	O
,	O
at	O
later	O
ages	O
,	O
when	O
in	O
vivo	O
levels	O
of	O
Brn3b	B
mRNA	O
are	O
high	O
,	O
FGF2	B
,	O
TGFbeta1	O
and	O
retinoic	O
acid	O
all	O
up	O
-	O
regulate	O
Brn3b	B
mRNA	O
expression	O
in	O
cultured	O
trigeminal	O
neurons	O
.	O

Since	O
NT-3	B
regulates	O
the	O
developmental	O
expression	O
of	O
Brn3a	B
,	O
Brn3a	B
may	O
mediate	O
some	O
of	O
the	O
effects	O
that	O
NT-3	B
exerts	O
on	O
sensory	O
neurons	O
and	O
their	O
progenitors	O
.	O

Similarly	O
,	O
Brn3b	B
may	O
mediate	O
some	O
of	O
the	O
effects	O
that	O
FGF2	B
,	O
TGFbeta1	O
and	O
retinoic	O
acid	O
have	O
on	O
neurons	O
.	O

In	O
this	O
study	O
we	O
have	O
examined	O
the	O
expression	O
of	O
murine	O
Hox	O
homeobox	O
containing	O
genes	O
by	O
in	O
situ	O
hybridisation	O
in	O
the	O
branchial	O
region	O
of	O
the	O
head	O
.	O

Genes	O
from	O
the	O
Hox	O
complexes	O
display	O
segmentally	O
restricted	O
domains	O
of	O
expression	O
in	O
the	O
developing	O
hindbrain	O
,	O
which	O
are	O
correlated	O
with	O
similar	O
restricted	O
domains	O
in	O
the	O
neural	O
crest	O
and	O
surface	O
ectoderm	O
of	O
the	O
branchial	O
arches	O
.	O

Comparison	O
of	O
related	O
genes	O
from	O
the	O
different	O
clusters	O
shows	O
that	O
subfamily	O
members	O
are	O
expressed	O
in	O
identical	O
rhombomeres	O
and	O
branchial	O
arches	O
.	O

These	O
patterns	O
suggest	O
a	O
combinatorial	O
system	O
for	O
specifying	O
regional	O
variation	O
in	O
the	O
head	O
,	O
which	O
we	O
refer	O
to	O
as	O
a	O
Hox	O
code	O
.	O

The	O
Hox	O
genes	O
also	O
display	O
dynamic	O
dorso	O
-	O
ventral	O
(	O
D	O
-	O
V	O
)	O
restrictions	O
in	O
the	O
developing	O
neural	O
tube	O
which	O
mirror	O
the	O
timing	O
and	O
spatial	O
distributions	O
of	O
the	O
birth	O
of	O
major	O
classes	O
of	O
neurons	O
in	O
the	O
CNS	O
.	O

Genes	O
in	O
the	O
Hox-2	O
cluster	O
all	O
have	O
a	O
similar	O
D	O
-	O
V	O
distribution	O
that	O
differs	O
from	O
that	O
of	O
genes	O
from	O
the	O
other	O
Hox	O
clusters	O
,	O
and	O
suggests	O
that	O
members	O
of	O
a	O
subfamily	O
may	O
be	O
used	O
to	O
specify	O
positional	O
values	O
to	O
different	O
subsets	O
of	O
cells	O
at	O
the	O
same	O
axial	O
level	O
.	O

These	O
results	O
are	O
discussed	O
in	O
terms	O
of	O
a	O
system	O
for	O
patterning	O
the	O
branchial	O
regions	O
of	O
the	O
vertebrate	O
head	O
,	O
and	O
evolution	O
of	O
head	O
structures	O
.	O

We	O
have	O
also	O
examined	O
aspects	O
of	O
the	O
transcriptional	O
regulation	O
of	O
Hox-2	O
genes	O
in	O
transgenic	O
mice	O
using	O
a	O
lacZ	O
reporter	O
gene	O
.	O

We	O
have	O
been	O
able	O
to	O
reconstruct	O
the	O
major	O
pattern	O
of	O
the	O
Hox-2.6	O
gene	O
on	O
the	O
basis	O
of	O
identical	O
expression	O
of	O
the	O
transgene	O
and	O
the	O
endogenous	O
gene	O
with	O
respect	O
to	O
timing	O
,	O
spatial	O
restrictions	O
and	O
tissue	O
-	O
specific	O
distributions	O
.	O

Deletion	O
analysis	O
has	O
enabled	O
us	O
to	O
identify	O
three	O
regions	O
involved	O
in	O
generating	O
this	O
pattern	O
.	O

Two	O
of	O
these	O
regions	O
have	O
the	O
properties	O
of	O
enhancers	O
which	O
are	O
capable	O
of	O
imposing	O
spatially	O
-	O
restricted	O
domains	O
of	O
expression	O
on	O
heterologous	O
promoters	O
.	O

We	O
have	O
generated	O
similar	O
Hox	O
-	O
lacZ	O
fusions	O
that	O
reconstruct	O
the	O
highly	O
restricted	O
patterns	O
of	O
the	O
Hox-2.1	B
and	O
Hox-2.8	B
genes	O
in	O
the	O
developing	O
nervous	O
system	O
,	O
supporting	O
our	O
in	O
situ	O
analysis	O
and	O
the	O
idea	O
of	O
a	O
Hox	O
code	O
.	O

These	O
transgenic	O
experiments	O
are	O
a	O
useful	O
step	O
in	O
examining	O
regulation	O
in	O
the	O
Hox	O
cascade	O
.	O

Tottering	B
mice	O
inherit	O
a	O
recessive	O
mutation	O
of	O
the	O
calcium	O
channel	O
alpha1A	B
subunit	O
that	O
causes	O
ataxia	O
,	O
polyspike	O
discharges	O
,	O
and	O
intermittent	O
dystonic	O
episodes	O
.	O

The	O
calcium	O
channel	O
alpha1A	B
subunit	O
gene	O
encodes	O
the	O
pore	O
-	O
forming	O
protein	O
of	O
P	O
/	O
Q	O
-	O
type	O
voltage	O
-	O
dependent	O
calcium	O
channels	O
and	O
is	O
predominantly	O
expressed	O
in	O
cerebellar	O
granule	O
and	O
Purkinje	O
neurons	O
with	O
moderate	O
expression	O
in	O
hippocampus	O
and	O
inferior	O
colliculus	O
.	O

Because	O
calcium	O
misregulation	O
likely	O
underlies	O
the	O
tottering	B
mouse	O
phenotype	O
,	O
calcium	O
channel	O
blockers	O
were	O
tested	O
for	O
their	O
ability	O
to	O
block	O
the	O
motor	O
episodes	O
.	O

Pharmacologic	O
agents	O
that	O
specifically	O
block	O
L	O
-	O
type	O
voltage	O
-	O
dependent	O
calcium	O
channels	O
,	O
but	O
not	O
P	O
/	O
Q	O
-	O
type	O
calcium	O
channels	O
,	O
prevented	O
the	O
inducible	O
dystonia	O
of	O
tottering	B
mutant	O
mice	O
.	O

Specifically	O
,	O
the	O
dihydropyridines	O
nimodipine	O
,	O
nifedipine	O
,	O
and	O
nitrendipine	O
,	O
the	O
benzothiazepine	O
diltiazem	O
,	O
and	O
the	O
phenylalkylamine	O
verapamil	O
all	O
prevented	O
restraint	O
-	O
induced	O
tottering	B
mouse	O
motor	O
episodes	O
.	O

Conversely	O
,	O
the	O
L	O
-	O
type	O
calcium	O
channel	O
agonist	O
Bay	O
K8644	O
induced	O
stereotypic	O
tottering	B
mouse	O
dystonic	O
at	O
concentrations	O
significantly	O
below	O
those	O
required	O
to	O
induce	O
seizures	O
in	O
control	O
mice	O
.	O

In	O
situ	O
hybridization	O
demonstrated	O
that	O
L	O
-	O
type	O
calcium	O
channel	O
alpha1C	O
subunit	O
mRNA	O
expression	O
was	O
up	O
-	O
regulated	O
in	O
the	O
Purkinje	O
cells	O
of	O
tottering	B
mice	O
.	O

Radioligand	O
binding	O
with	O
[	O
3H	O
]	O
nitrendipine	O
also	O
revealed	O
a	O
significant	O
increase	O
in	O
the	O
density	O
of	O
L	O
-	O
type	O
calcium	O
channels	O
in	O
tottering	B
mouse	O
cerebellum	O
.	O

These	O
data	O
suggest	O
that	O
although	O
a	O
P	O
/	O
Q	O
-	O
type	O
calcium	O
channel	O
mutation	O
is	O
the	O
primary	O
defect	O
in	O
tottering	B
mice	O
,	O
L	O
-	O
type	O
calcium	O
channels	O
may	O
contribute	O
to	O
the	O
generation	O
of	O
the	O
intermittent	O
dystonia	O
observed	O
in	O
these	O
mice	O
.	O

The	O
susceptibility	O
of	O
L	O
-	O
type	O
calcium	O
channels	O
to	O
voltage	O
-	O
dependent	O
facilitation	O
may	O
promote	O
this	O
abnormal	O
motor	O
phenotype	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
shows	O
that	O
fission	O
yeast	O
centromeres	O
and	O
telomeres	O
make	O
up	O
specific	O
spatial	O
arrangements	O
in	O
the	O
nucleus	O
.	O

Their	O
positioning	O
and	O
clustering	O
are	O
cell	O
cycle	O
regulated	O
.	O

In	O
G2	O
,	O
centromeres	O
cluster	O
adjacent	O
to	O
the	O
spindle	O
pole	O
body	O
(	O
SPB	O
)	O
,	O
while	O
in	O
mitosis	O
,	O
their	O
association	O
with	O
each	O
other	O
and	O
with	O
the	O
SPB	O
is	O
disrupted	O
.	O

Similarly	O
,	O
telomeres	O
cluster	O
at	O
the	O
nuclear	O
periphery	O
in	O
G2	O
and	O
their	O
associations	O
are	O
disrupted	O
in	O
mitosis	O
.	O

Mitotic	O
centromeres	O
interact	O
with	O
the	O
spindle	O
.	O

They	O
remain	O
undivided	O
until	O
the	O
spindle	O
reaches	O
a	O
critical	O
length	O
,	O
then	O
separate	O
and	O
move	O
towards	O
the	O
poles	O
.	O

This	O
demonstrated	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
anaphase	O
A	O
occurs	O
in	O
fission	O
yeast	O
.	O

The	O
mode	O
of	O
anaphase	O
A	O
and	O
B	O
is	O
similar	O
to	O
that	O
of	O
higher	O
eukaryotes	O
.	O

In	O
nda3	O
and	O
cut7	O
mutants	O
defective	O
in	O
tubulin	O
of	O
a	O
kinesin	O
-	O
related	O
motor	O
,	O
cells	O
are	O
blocked	O
in	O
early	O
stages	O
of	O
mitosis	O
due	O
to	O
the	O
absence	O
of	O
the	O
spindle	O
,	O
and	O
centromeres	O
dissociate	O
but	O
remain	O
close	O
to	O
the	O
SPB	O
,	O
whereas	O
in	O
a	O
metaphase	O
-	O
arrested	O
nuc2	B
mutant	O
,	O
they	O
reside	O
at	O
the	O
middle	O
of	O
the	O
spindle	O
.	O

FISH	O
is	O
therefore	O
a	O
powerful	O
tool	O
for	O
analyzing	O
mitotic	O
chromosome	O
movement	O
and	O
disjunction	O
using	O
various	O
mutants	O
.	O

Surprisingly	O
,	O
in	O
top2	B
defective	O
in	O
DNA	O
topoisomerase	O
II	O
,	O
while	O
most	O
chromatid	O
DNAs	O
remain	O
undivided	O
,	O
sister	O
centromeres	O
are	O
separated	O
.	O

Significance	O
of	O
this	O
finding	O
is	O
discussed	O
.	O

In	O
contrast	O
,	O
most	O
chromatid	O
DNAs	O
are	O
separated	O
but	O
telomeric	O
DNAs	O
are	O
not	O
in	O
cut1	O
mutant	O
.	O

In	O
cut1	O
,	O
the	O
dependence	O
of	O
SPB	O
duplication	O
on	O
the	O
completion	O
of	O
mitosis	O
is	O
abolished	O
.	O

In	O
crm1	B
mutant	O
cells	O
defective	O
in	O
higher	O
-	O
order	O
chromosome	O
organization	O
,	O
the	O
interphase	O
arrangements	O
of	O
centromeres	O
and	O
telomeres	O
are	O
disrupted	O
.	O

We	O
have	O
continued	O
our	O
studies	O
on	O
the	O
import	O
pathway	O
of	O
the	O
precursor	O
to	O
yeast	O
cytochrome	O
c	O
oxidase	O
subunit	O
Va	O
(	O
pVa	O
)	O
,	O
a	O
mitochondrial	O
inner	O
membrane	O
protein	O
.	O

Previous	O
work	O
on	O
this	O
precursor	O
demonstrated	O
that	O
import	O
of	O
pVa	O
is	O
unusually	O
efficient	O
,	O
and	O
that	O
inner	O
membrane	O
localization	O
is	O
directed	O
by	O
a	O
membrane	O
-	O
spanning	O
domain	O
in	O
the	O
COOH	O
-	O
terminal	O
third	O
of	O
the	O
protein	O
.	O

Here	O
we	O
report	O
the	O
results	O
of	O
studies	O
aimed	O
at	O
analyzing	O
the	O
intramitochondrial	O
sorting	O
of	O
pVa	O
,	O
as	O
well	O
as	O
the	O
role	O
played	O
by	O
ancillary	O
factors	O
in	O
import	O
and	O
localization	O
of	O
the	O
precursor	O
.	O

We	O
found	O
that	O
pVa	O
was	O
efficiently	O
imported	O
and	O
correctly	O
sorted	O
in	O
mitochondria	O
prepared	O
from	O
yeast	O
strains	O
defective	O
in	O
the	O
function	O
of	O
either	O
mitochondrial	O
heat	O
shock	O
protein	O
(	O
hsp	O
)	O
60	O
or	O
hsp70	B
.	O

Under	O
identical	O
conditions	O
the	O
import	O
and	O
sorting	O
of	O
another	O
mitochondrial	O
protein	O
,	O
the	O
precursor	O
to	O
the	O
beta	O
subunit	O
of	O
the	O
F1	O
ATPase	O
,	O
was	O
completely	O
defective	O
.	O

Consistent	O
with	O
previous	O
results	O
demonstrating	O
that	O
the	O
subunit	O
Va	O
precursor	O
is	O
loosely	O
folded	O
,	O
we	O
found	O
that	O
pVa	O
could	O
be	O
efficiently	O
imported	O
into	O
mitochondria	O
after	O
translation	O
in	O
wheat	O
germ	O
extracts	O
.	O

This	O
results	O
suggests	O
that	O
normal	O
levels	O
of	O
extramitochondrial	O
hsp70	B
are	O
also	O
not	O
required	O
for	O
import	O
of	O
the	O
protein	O
.	O

The	O
results	O
of	O
this	O
study	O
enhance	O
our	O
understanding	O
of	O
the	O
mechanism	O
by	O
which	O
pVa	O
is	O
routed	O
to	O
the	O
mitochondrial	O
inner	O
membrane	O
.	O

They	O
suggest	O
that	O
while	O
the	O
NH2	O
terminus	O
of	O
pVa	O
is	O
exposed	O
to	O
the	O
matrix	O
and	O
processed	O
by	O
the	O
matrix	O
metalloprotease	O
,	O
the	O
protein	O
remains	O
anchored	O
to	O
the	O
inner	O
membrane	O
before	O
being	O
assembled	O
into	O
a	O
functional	O
holoenzyme	O
complex	O
.	O

ENP1	B
is	O
an	O
essential	O
Saccharomyces	O
cerevisiae	O
gene	O
encoding	O
a	O
483	O
amino	O
acid	O
polypeptide	O
.	O

Enp1	B
protein	O
is	O
localized	O
in	O
the	O
nucleus	O
and	O
concentrated	O
in	O
the	O
nucleolus	O
.	O

An	O
enp1	B
-	I
1	I
temperature	O
-	O
sensitive	O
mutant	O
inhibited	O
35S	O
pre	O
-	O
rRNA	O
early	O
processing	O
at	O
sites	O
A	O
(	O
0	O
)	O
,	O
A	O
(	O
1	O
)	O
and	O
A	O
(	O
2	O
)	O
as	O
shown	O
by	O
northern	O
analysis	O
of	O
steady	O
state	O
levels	O
of	O
rRNA	O
precursors	O
.	O

Pulse	O
-	O
chase	O
analysis	O
further	O
revealed	O
that	O
the	O
enp1	B
-	I
1	I
strain	O
was	O
defective	O
in	O
the	O
synthesis	O
of	O
20S	O
pre	O
-	O
rRNA	O
and	O
hence	O
18S	O
rRNA	O
,	O
which	O
led	O
to	O
reduced	O
formation	O
of	O
40S	O
ribosomal	O
subunits	O
.	O

Co	O
-	O
precipitation	O
analysis	O
revealed	O
that	O
Enp1	B
was	O
associated	O
with	O
Nop1	B
protein	O
,	O
as	O
well	O
as	O
with	O
U3	O
and	O
U14	O
RNAs	O
,	O
two	O
snoRNAs	O
implicated	O
in	O
early	O
pre	O
-	O
rRNA	O
processing	O
steps	O
.	O

These	O
results	O
suggest	O
a	O
direct	O
role	O
for	O
Enp1	B
in	O
the	O
early	O
steps	O
of	O
rRNA	O
processing	O
.	O

The	O
PUT1	B
gene	O
of	O
Saccharomyces	O
cerevisiae	O
,	O
believed	O
to	O
encode	O
proline	O
oxidase	O
,	O
has	O
been	O
completely	O
sequenced	O
and	O
contains	O
an	O
open	O
reading	O
frame	O
capable	O
of	O
encoding	O
a	O
polypeptide	O
of	O
476	O
amino	O
acids	O
in	O
length	O
.	O

The	O
amino	O
terminus	O
of	O
the	O
protein	O
deduced	O
from	O
the	O
DNA	O
sequence	O
has	O
a	O
characteristic	O
mitochondrial	O
import	O
signal	O
;	O
two	O
PUT1-lacZ	B
gene	O
fusions	O
were	O
constructed	O
that	O
produced	O
mitochondrially	O
localized	O
beta	O
-	O
galactosidase	O
in	O
vivo	O
.	O

The	O
transcription	O
initiation	O
and	O
termination	O
sites	O
of	O
the	O
PUT1	B
mRNA	O
were	O
determined	O
.	O

By	O
using	O
a	O
PUT1-lacZ	B
gene	O
fusion	O
that	O
makes	O
a	O
cytoplasmic	O
beta	O
-	O
galactosidase	O
,	O
the	O
regulation	O
of	O
the	O
PUT1	B
gene	O
was	O
studied	O
.	O

PUT1	B
is	O
inducible	O
by	O
proline	O
,	O
responds	O
only	O
slightly	O
to	O
carbon	O
catabolite	O
repression	O
,	O
and	O
is	O
not	O
regulated	O
by	O
the	O
cytochrome	O
activator	O
proteins	O
HAP1	B
and	O
HAP2	B
.	O

The	O
PUT1	B
gene	O
is	O
under	O
oxygen	O
regulation	O
;	O
expression	O
in	O
anaerobically	O
grown	O
cells	O
is	O
10-fold	O
lower	O
than	O
in	O
aerobically	O
grown	O
cells	O
.	O

Oxygen	O
regulation	O
is	O
abolished	O
when	O
cells	O
are	O
respiratory	O
deficient	O
.	O

PUT1	B
expression	O
in	O
a	O
[	O
rho-	O
]	O
strain	O
grown	O
either	O
aerobically	O
or	O
anaerobically	O
is	O
as	O
high	O
as	O
that	O
seen	O
in	O
a	O
[	O
rho+	O
]	O
strain	O
grown	O
aerobically	O
.	O

Studies	O
on	O
PUT1	B
promoter	O
deletions	O
define	O
a	O
region	O
between	O
positions	O
-458	O
and	O
-293	O
from	O
the	O
translation	O
initiation	O
site	O
that	O
is	O
important	O
for	O
full	O
expression	O
of	O
the	O
PUT1	B
gene	O
and	O
required	O
for	O
oxygen	O
regulation	O
.	O

The	O
cycl-362	O
allele	O
contains	O
a	O
point	O
mutation	O
that	O
generates	O
an	O
aberrant	O
AUG	O
codon	O
upstream	O
of	O
the	O
normal	O
CYC1	B
translation	O
initiation	O
codon	O
.	O

Mutants	O
containing	O
this	O
allele	O
express	O
only	O
about	O
2	O
%	O
of	O
normal	O
iso-1-cytochrome	O
c	O
,	O
presumably	O
due	O
to	O
translation	O
initiation	O
at	O
the	O
upstream	O
AUG	O
,	O
termination	O
at	O
a	O
UAA	O
sequence	O
six	O
codons	O
downstream	O
,	O
and	O
failure	O
to	O
reinitiate	O
at	O
the	O
normal	O
AUG	O
codon	O
two	O
nucleotides	O
later	O
.	O

Both	O
intragenic	O
and	O
extragenic	O
revertants	O
of	O
cycl-362	O
,	O
expressing	O
elevated	O
levels	O
of	O
iso-1-cytochrome	O
c	O
,	O
have	O
been	O
isolated	O
simply	O
by	O
selecting	O
for	O
growth	O
on	O
lactate	O
medium	O
.	O

Here	O
we	O
describe	O
an	O
improved	O
method	O
for	O
isolating	O
and	O
readily	O
distinguishing	O
cis-	O
from	O
trans	O
-	O
acting	O
suppressors	O
of	O
the	O
upstream	O
AUG	O
.	O

Eight	O
different	O
genes	O
,	O
designated	O
sua1-sua8	B
,	O
are	O
represented	O
in	O
our	O
current	O
collection	O
of	O
extragenic	O
suppressors	O
;	O
all	O
are	O
recessive	O
and	O
enhance	O
iso-1-cytochrome	O
c	O
levels	O
to	O
10	O
-	O
60	O
%	O
of	O
normal	O
.	O

None	O
of	O
the	O
sua	O
genes	O
is	O
allelic	O
to	O
SUI2	B
or	O
sui3	B
,	O
which	O
encode	O
eIF-2	O
alpha	O
and	O
eIF-2	O
beta	O
,	O
respectively	O
,	O
or	O
to	O
SUI1	B
.	O

Many	O
of	O
the	O
suppressors	O
exhibit	O
pleiotropic	O
phenotypes	O
,	O
including	O
slow	O
growth	O
,	O
cold	O
(	O
16	O
degrees	O
C	O
)	O
and	O
heat	O
(	O
37	O
degrees	O
C	O
)	O
sensitivity	O
.	O

These	O
phenotypes	O
have	O
been	O
exploited	O
to	O
clone	O
the	O
SUA5	B
,	O
SUA7	B
and	O
SUA8	B
genes	O
,	O
which	O
are	O
presently	O
being	O
characterized	O
.	O

The	O
structure	O
of	O
cyc1	B
-	I
362	I
and	O
the	O
number	O
of	O
sua	O
genes	O
already	O
uncovered	O
suggest	O
that	O
the	O
SUA	O
genes	O
are	O
likely	O
to	O
encode	O
factors	O
affecting	O
several	O
different	O
cellular	O
processes	O
,	O
including	O
translation	O
initiation	O
,	O
mRNA	O
stability	O
and	O
possibly	O
transcription	O
start	O
site	O
selection	O
.	O

The	O
yeast	O
Saccharomyces	O
cerevisiae	O
has	O
a	O
genetic	O
program	O
for	O
selecting	O
and	O
assembling	O
a	O
bud	O
site	O
on	O
the	O
cell	O
cortex	O
.	O

Yeast	O
cells	O
confine	O
their	O
growth	O
to	O
the	O
emerging	O
bud	O
,	O
a	O
process	O
directed	O
by	O
cortical	O
patches	O
of	O
actin	O
filaments	O
within	O
the	O
bud	O
.	O

We	O
have	O
investigated	O
how	O
cells	O
regulate	O
budding	O
in	O
response	O
to	O
osmotic	O
stress	O
,	O
focusing	O
on	O
the	O
role	O
of	O
the	O
high	O
osmolarity	O
glycerol	O
response	O
(	O
HOG	O
)	O
pathway	O
in	O
mediating	O
this	O
regulation	O
.	O

An	O
increase	O
in	O
external	O
osmolarity	O
induces	O
a	O
growth	O
arrest	O
in	O
which	O
actin	O
filaments	O
are	O
lost	O
from	O
the	O
bud	O
.	O

This	O
is	O
followed	O
by	O
a	O
recovery	O
phase	O
in	O
which	O
actin	O
filaments	O
return	O
to	O
their	O
original	O
locations	O
and	O
growth	O
of	O
the	O
original	O
bud	O
resumes	O
.	O

After	O
recovery	O
from	O
osmotic	O
stress	O
,	O
haploid	O
cells	O
retain	O
an	O
axial	O
pattern	O
of	O
bud	O
site	O
selection	O
while	O
diploids	O
change	O
their	O
bipolar	O
budding	O
pattern	O
to	O
an	O
increased	O
bias	O
for	O
forming	O
a	O
bud	O
on	O
the	O
opposite	O
side	O
of	O
the	O
cell	O
from	O
the	O
previous	O
bud	O
site	O
.	O

Mutants	O
lacking	O
the	O
mitogen	O
-	O
activated	O
protein	O
(	O
MAP	O
)	O
kinase	O
encoded	O
by	O
HOG1	B
or	O
the	O
MAP	O
kinase	O
kinase	O
encoded	O
by	O
PBS2	B
(	O
previously	O
HOG4	B
)	O
show	O
a	O
similar	O
growth	O
arrest	O
after	O
osmotic	O
stress	O
.	O

However	O
,	O
in	O
the	O
recovery	O
phase	O
,	O
the	O
mutant	O
cells	O
(	O
a	O
)	O
do	O
not	O
restart	O
growth	O
of	O
the	O
original	O
bud	O
but	O
rather	O
start	O
a	O
new	O
bud	O
,	O
(	O
b	O
)	O
fail	O
to	O
restore	O
actin	O
filaments	O
to	O
the	O
original	O
bud	O
but	O
move	O
them	O
to	O
the	O
new	O
one	O
,	O
and	O
(	O
c	O
)	O
show	O
a	O
more	O
random	O
budding	O
pattern	O
.	O

These	O
defects	O
are	O
elicited	O
by	O
an	O
increase	O
in	O
osmolarity	O
and	O
not	O
by	O
other	O
environmental	O
stresses	O
(	O
e.g.	O
,	O
heat	O
shock	O
or	O
change	O
in	O
carbon	O
source	O
)	O
that	O
also	O
cause	O
a	O
temporary	O
growth	O
arrest	O
and	O
shift	O
in	O
actin	O
distribution	O
.	O

Thus	O
,	O
the	O
HOG	O
pathway	O
is	O
required	O
for	O
repositioning	O
of	O
the	O
actin	O
cytoskeleton	O
and	O
the	O
normal	O
spatial	O
patterns	O
of	O
cell	O
growth	O
after	O
recovery	O
from	O
osmotic	O
stress	O
.	O

A	O
cDNA	O
clone	O
encoding	O
Arabidopsis	O
thaliana	O
galactokinase	O
was	O
fortuitously	O
isolated	O
during	O
the	O
course	O
of	O
a	O
screen	O
for	O
plant	O
homologues	O
of	O
a	O
Saccharomyces	O
cerevisiae	O
peroxisome	O
assembly	O
gene	O
,	O
PAS9	B
.	O

Clones	O
were	O
sought	O
which	O
restored	O
the	O
ability	O
of	O
pas9	B
cells	O
to	O
grow	O
on	O
oleate	O
as	O
a	O
sole	O
carbon	O
source	O
,	O
as	O
oleate	O
metabolism	O
requires	O
peroxisomal	O
beta	O
-	O
oxidation	O
and	O
therefore	O
functional	O
peroxisomes	O
.	O

Subsequent	O
experiments	O
showed	O
that	O
high	O
level	O
expression	O
of	O
the	O
galactokinase	O
cDNA	O
did	O
not	O
complement	O
the	O
peroxisomal	O
assembly	O
defect	O
,	O
but	O
instead	O
permitted	O
the	O
cells	O
to	O
grow	O
on	O
agar	O
plates	O
in	O
the	O
absence	O
of	O
an	O
external	O
carbon	O
source	O
.	O

Agar	O
plates	O
were	O
shown	O
to	O
contain	O
a	O
small	O
amount	O
of	O
galactose	O
released	O
from	O
the	O
agar	O
as	O
a	O
result	O
of	O
autoclaving	O
.	O

The	O
galactokinase	O
clone	O
was	O
shown	O
to	O
be	O
functional	O
,	O
as	O
it	O
could	O
complement	O
a	O
S.	O
cerevisiae	O
galactokinase	O
mutant	O
.	O

Galactokinase	O
is	O
a	O
single	O
copy	O
gene	O
in	O
Arabidopsis	O
,	O
which	O
has	O
been	O
designated	O
AGK1	O
,	O
and	O
is	O
expressed	O
in	O
all	O
the	O
major	O
organs	O
of	O
the	O
plant	O
.	O

Human	O
cystathionine	O
beta	O
-	O
synthase	O
(	O
CBS	O
;	O
EC	O
4.2.1.22	O
)	O
deficiency	O
results	O
in	O
a	O
recessive	O
genetic	O
disorder	O
whose	O
clinical	O
and	O
biochemical	O
manifestations	O
vary	O
greatly	O
among	O
affected	O
individuals	O
.	O

In	O
an	O
effort	O
to	O
identify	O
and	O
analyze	O
mutations	O
in	O
the	O
human	O
CBS	O
gene	O
,	O
we	O
have	O
developed	O
a	O
yeast	O
expression	O
system	O
for	O
human	O
CBS	O
.	O

We	O
have	O
cloned	O
and	O
sequenced	O
a	O
human	O
cDNA	O
that	O
codes	O
for	O
CBS	O
and	O
have	O
expressed	O
the	O
human	O
CBS	O
protein	O
in	O
yeast	O
cells	O
lacking	O
endogenous	O
CBS	O
.	O

The	O
human	O
enzyme	O
produced	O
in	O
yeast	O
is	O
functional	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

We	O
have	O
also	O
cloned	O
and	O
sequenced	O
the	O
yeast	O
gene	O
,	O
CYS4	B
,	O
that	O
codes	O
for	O
CBS	O
.	O

The	O
predicted	O
human	O
and	O
yeast	O
CBS	O
proteins	O
are	O
38	O
%	O
identical	O
and	O
72	O
%	O
similar	O
to	O
each	O
other	O
,	O
as	O
well	O
as	O
sharing	O
significant	O
similarity	O
with	O
bacterial	O
cysteine	O
synthase	O
.	O

These	O
results	O
demonstrate	O
the	O
evolutionary	O
conservation	O
of	O
CBS	O
and	O
establish	O
the	O
utility	O
of	O
a	O
yeast	O
expression	O
system	O
for	O
studying	O
human	O
CBS	O
.	O

It	O
is	O
thought	O
that	O
DNA	O
replication	O
and	O
mitosis	O
in	O
yeast	O
are	O
triggered	O
by	O
oscillations	O
in	O
the	O
level	O
of	O
G1-specific	O
(	O
CLN1	B
and	O
CLN2	B
)	O
and	O
G2-specific	O
(	O
CLB1-CLB4	B
)	O
cyclins	O
,	O
which	O
determine	O
the	O
substrate	O
specificity	O
of	O
the	O
CDC28	B
protein	O
kinase	O
.	O

It	O
is	O
not	O
understood	O
how	O
the	O
time	O
and	O
order	O
of	O
appearance	O
of	O
different	O
cyclin	O
types	O
are	O
determined	O
.	O

We	O
show	O
here	O
that	O
CLB2	B
proteolysis	O
,	O
which	O
is	O
important	O
for	O
transition	O
from	O
mitosis	O
to	O
G1	O
,	O
is	O
not	O
confined	O
to	O
a	O
narrow	O
window	O
at	O
the	O
end	O
of	O
mitosis	O
as	O
previously	O
thought	O
but	O
continues	O
until	O
reactivation	O
of	O
CDC28	B
by	O
CLN	O
cyclins	O
toward	O
the	O
end	O
of	O
the	O
subsequent	O
G1	O
period	O
.	O

Thus	O
,	O
cell	O
cycle	O
-	O
regulated	O
proteolysis	O
prevents	O
accumulation	O
of	O
G2-specific	O
CLB	O
cyclins	O
during	O
G1	O
and	O
thereby	O
ensures	O
that	O
the	O
CLN	O
-	O
associated	O
forms	O
of	O
the	O
CDC28	B
kinase	O
are	O
activated	O
without	O
interference	O
from	O
CLB	O
cyclins	O
.	O

Accumulation	O
of	O
CLN	O
cyclins	O
leads	O
to	O
inactivation	O
of	O
CLB	O
cyclin	O
proteolysis	O
,	O
which	O
is	O
a	O
precondition	O
for	O
subsequent	O
activation	O
of	O
G2-specific	O
B	O
-	O
type	O
cyclins	O
.	O

The	O
RES1	B
-	I
1	I
mutation	O
was	O
isolated	O
on	O
the	O
basis	O
of	O
its	O
ability	O
to	O
allow	O
MATa	O
/	O
MAT	B
alpha	O
diploid	O
Saccharomyces	O
cerevisiae	O
cells	O
to	O
express	O
a	O
late	O
sporulation	O
-	O
regulated	O
gene	O
,	O
SPR3	B
,	O
in	O
the	O
presence	O
of	O
excess	O
copies	O
of	O
RME1	B
.	O

RME1	B
is	O
a	O
repressor	O
of	O
meiosis	O
that	O
is	O
normally	O
expressed	O
in	O
cells	O
that	O
lack	O
the	O
a1	B
/	O
alpha	O
2	O
repressor	O
encoded	O
by	O
MAT	B
.	O

The	O
RES1	B
-	I
1	I
mutation	O
also	O
supports	O
sporulation	O
in	O
mat	B
-	O
insufficient	O
diploids	O
.	O

This	O
phenotype	O
does	O
not	O
result	O
from	O
a	O
failure	O
to	O
express	O
RME1	B
and	O
is	O
not	O
due	O
to	O
activation	O
of	O
the	O
silent	O
copies	O
of	O
mating	O
type	O
information	O
.	O

RES1	B
-	I
1	I
activates	O
sporulation	O
by	O
allowing	O
IME1	B
accumulation	O
in	O
all	O
cell	O
types	O
,	O
irrespective	O
of	O
the	O
presence	O
of	O
the	O
MAT	B
products	O
.	O

IME1	B
is	O
still	O
responsive	O
to	O
RME1	B
in	O
RES1	B
-	I
1	I
cells	O
,	O
since	O
double	O
mutants	O
(	O
rme1	B
RES1	B
-	I
1	I
)	O
that	O
are	O
deficient	O
at	O
MAT	B
can	O
sporulate	O
better	O
than	O
either	O
single	O
mutant	O
.	O

RES1	B
-	I
1	I
is	O
not	O
an	O
allele	O
of	O
IME1	B
.	O

